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GENERAL INTRODUCTION 
Swine dysentery is a mucohemmorrhagic djarrheal disease affecting 
mainly feeder pigs (29). Its etiologic agent has been demonstrated to be 
Serpulina hyodysenteriae, a gram negative spirochete (27, 29, 106). The costs 
associated with morbidity and mortality (79) due to swine dysentery have 
recently totaled 180 million dollars annually for the U.S. pork industry (47). 
Though antibiotics are effective in treating the disease, no effective 
vaccine against swine dysentery has been developed for pigs nor do swine 
develop complete immunity once recovered from the disease (42, 47, 106). 
While specific antibody against S. hyodysenteriae is seen in serum and intestinal 
secretions upon infection, it is not wholly protective (90, 122). 
Cholera toxin used as an oral adjuvant has been shown to affect a greater 
specific immune response at mucosal surfaces for some antigens (14, 31 ). 
Protection against Sendai virus infection has also been shown with this model 
(61 ). 
The research described in this thesis was performed to ascertain if oral 
imrnuniz.ation with cholera toxin and S. hyodysenteriae cellular antigens in mice 
would promote a greater, more efficient antibody immune response against S. 
hyodysenteriae than immunization and/or infection without cholera toxin and if a 
stronger antibody response than that generated by conventional immunization 
and/or infection allowed for protection against the cecitis induced by the 
bacteria. This was accomplished through enzyme-linked immunosorbant assay of 
serum antibody and ELISPOT examination of antibody secreting cells (ASC) in 
the spleen and mesenteric lymph nodes. 
2 
Explanation of thesis format: This thesis includes one manuscript 
written for Infection and Immunity. A general introduction and a general review 
of the liturature precede the manuscript. A general summary immediately 
follows the manuscript. Liturature cited in the literature review, general 
introduction, and general summary then follows. 
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LITERATURE REVIEW 
Swine Dysentery 
Swine dysentery is an intestinal disease affecting pigs primarily during 
the growing-finishing period. Clinical signs generally include a mucohemmorr-
hagic diarrhea resulting from lesions of the large intestine. Alternately, swine 
dysentery has been referred to as vibrionic dysentery, bloody scours, bloody 
dysentery , black scours, necrotic enteritis and mucohemorrhagic diarrhea (29). 
Its importance lies in the economic toll of an estimated 180 million dollars 
exacted annually from the U.S. pork industry (47). This value includes 
monetary losses due to mortality, decreased rate of gain and preventative use of 
antibiotics in feed (79). Swine dysentery has been reported in most pig-rearing 
countries of the world (91) . 
Whiting, Doyle, and Spray first described swine dysentery at Purdue 
University in 1921 (116). Though no etiologic agent was described for the 
disease at that time, an infectious etiology was suspected based on the following 
observations. Outbreaks of swine dysentery were documented after the intro-
duction of new animals onto farms from stock yards. Also, the disease was 
transferred to naive swine via feces, stomach tissue or large intestine from sick 
pigs (117, 118). In the following years Bacillus suipestik1, Vihrio spp., 
Salmonella spp., paratyphoid organisms, "protozoal" spirochetes, and balantidia 
were all implicated as the causative agent of swine dysentery, but none were ever 
conclusively demonstrated as such (2, 16, 39, 117). 
It was not until 1971 that two groups simultaneouly identified a large 
spirochete ( Treponema hyodysenteriae) as the etiologic agent of swine dysentery. 
Harris et. al. at Iowa State University (27) and Taylor & Alexander (106) at 
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Cambridge University were able to isolate T. hyodysenteriae and reproduce 
disease by administration of the bacteria to pigs. Twenty years later the genus 
name was changed to Serpula based on DNA-DNA reassociation experiments, 
sodium dodecyl sulfate-polyacryalmide gel electrophoresis of cell proteins, and 
16S rRNA sequence analysis. The results of these tests showed S. hyodysenteriae 
and a closely related nonpathogenic spirochete, S. innocens, to be unique from 
various other identified spirochete genera including TreponemE, Leptospira , 
Spirochaeta, and Borrelia (87, 102). The genus was subsequently changed to 
Serpulina due to an oversight that Serpula was already a genus of wood rot 
fungus (103) . 
Serpulina hyodysenteriae is a motile Gram negative-staining, loosely 
coiled spirochete measuring 6 to 8.5 µm in length and 320 to 380 nm in diameter 
with a guanine-plus-cytosine content of 25.8% and 7 to 13 endoflagella. The 
flagella are inserted at each end of the cell and overlap in the middle. An outer 
membrane covers the entire organism (27). 
Substrate amounts of oxygen are consumed by S. hyodysenteriae with 
growth of the bacteria being enhanced by the presence of l % oxygen in the 
media (100). Serpulina hyodysenteriae utilizes a limited number of 
carbohydrates for energy, namely glucose and maltose, the end products of 
fermentation being acetate, butyrate, H2, and C02. However, the bacteria has 
also been shown to utilize fructose, sucrose, galactose, trehalose, N-acetyl-
glucosamine, glucosamine, mannose, and pyruvate as growth substrates (100). 
Biochemically, th.e organism is negative for catalase, cytochrome oxidase, the 
production of hydrogen sulfide, gelatin hydrolysis, meat hydrolysis, glycine 
tolerance, starch hydrolysis, and urease while being positive for bile tolerance, 
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esculin hydrolysis, iodacetic acid tolerance, and indole production (29). 
Serpulina hyodysenteriae has also been shown to use cholesterol in membrane 
synthesis (99). The bacteria can be propagated both on solid and in liquid media 
(51). 
Most pathogenic strains of S. hyodysenteriae produce a beta hemolysin 
as opposed to a incomplete hemolysis produced by S. innocens. This feature 
along with enteropathogenicity in mice or pigs is considered to be the definitive 
test routinely used to differentiate between the two species (29). 
Infection of pigs with S. hyodysenteriae is most often accomplished by 
ingestion of feces from other pigs that are currently shedding the bacteria. 
Asymptomatic pigs have been demonstrated to shed S. hyodysenteriae for as long 
as 89 days post infection (41). However, this is not the sole route of 
transmission. Any number of mechanical means can spread the disease including 
contaminated boots, tires, and animals. Once established in a herd, S. 
hyodysenteriae can persist for over two weeks in soil and over two months in 
water with colder temperatures (4°C) supporting the longest periods of viability. 
In addition, mice are considered to be resevoirs of the disease since they have 
been shown to shed the bacteria for long periods of time (over four months) and 
their feces have also been shown to cause infection upon ingestion by pigs 
(29, 41). Long term infection of mice with S. hyodysenteriae and the 
accompanying cecitis make mice a common choice for the laboratory model of 
swine dysentery (41, 75). Also used as models are chicks (106), rabbits (53) , 
and guinea pigs ( 40). 
In the porcine large intestine, S. hyodysenteriae is attracted to the mucus 
covering the gut via chemotaxis (48). Because of this phenomenon and the 
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ability of the organism to move efficiently through mucus, the bacteria are able 
to directly interact with the epithelium. It is in this location that organisms 
multiply, particularly in the crypts of Lieberkuehn, and trigger the detrimental 
effects seen in the host ( 119, 120). 
Potential virulence factors of S. hyodysenteriae have been described. 
These include the aforementioned hemolysin (49, 50, 54, 58, 93-96) , 
lipopolysaccharide (LPS) (29), enzymes (100) , and motilty (29). 
The beta hemolysin (or possibly the beta hemolysins (35)) of S. 
hyodysenteriae has been suggested to be a protein associated with lipids or a 
lipoprotein (94). Adhesive and lytic capabilities have been ascribed to this 
molecule (74) and its probable substrate is a lipophilic molecule (47) . The 
hemolysirr is oxygen stable and heat labile (94). Estimates of molecular mass 
have varied including 74 kilodaltons (kDa), 26.9 kDa, and 19 kDa (50, 74, 94). 
A hemolysin gene termed tly has been identified for S. hyodysenteriae, but may 
not be the sole hemolysin present (35). The molecule is cytotoxic for several 
types of cell cultures (29) including fibroblasts and porcine lymphocytes (49). 
Colonic loops from germfree pigs have been shown to sustain epithelial cell 
damage in the intercrypt zone when injected with high levels S. hyodysenteriae 
hemolysin (100,000 hemolytic units) (64). The lytic process is temperature 
dependent for red blood cells and appears to be associated with swelling for both 
red blood cells and porcine epithelial cells (29, 93). Lipolytic and proteolytic 
actions or the requirement for divalent cations are likely not involved in the 
hemolysin's lytic mechanism (94). The action causing red blood cell lysis has 
been suggested to be a change in cell permeability due to digestion or disruption 
of a membrane component. Production of beta hemolysin by S. hyodysenteriae 
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has been reported to peak during the late-logarithmic phase and extracellular 
amounts can be increased with supplementation of yeast core RNA or sodium 
RNA (54, 58, 88). The beta hemolysin of S. hyodysenteriae and the alpha 
hemolysin of S. innocen.s have been found to differ in phospholipid sensitivity, 
hemolytic spectra, specific activity on rabbit erythrocytes and lysing efficiency of 
bovine, ovine, equine, or porcine erythrocytes where the beta hemolysin was a 
more effective lytic agent (95). No homologies have been found between the 
hemolysin of S. hyodysenteriae and the nucleic acid and protein characteristics of 
other reported hemolysins (74). 
In 1979, Baum and Joens fust described an LPS for S. hyodysenteriae 
(29). This molecule is dissimilar to that extracted from other Gram negative 
organisms, such as Escherichia col1, due to the absense of lipid A (25, 47). The 
LPS has been shown to be endotoxic with possible direct action on porcine 
epithelial cells of the large intestine (83). It has been reported to be toxic for 
murine macrophages plus having the ability to promote greater complement (C3) 
and immunoglobulin G-Fc receptor-mediated phagocytosis (23, 81). The LPS is 
an agent of chemotaxis both for neutrophils and monocytes while also causing 
lymphocyte proliferation and increased la expression on murine macrophages 
(47). In the presence of S. hyodysenteriae endotoxin (LPS + protein) murine 
peritoneal exudate cells (PEC) show increased production of interleukin-I (lL-1) 
and tumor necrosis factor (TNF) (23, 29). These two substance can up-regulate 
many more products involved in inflammation and general immune system 
activity such as prostaglandin E2, increased numbers of MHC class I or II 
molecules, intercellular adhesion molecule- I (ICAM-1), endothelial leukocyte 
adhesion molecule-I (ELAM-I), platelet activating factor (PAF), IL-2, 
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granulocyte/macrophage colony stimulating factor (GM-CSF), and IL-6 (79). ft 
has also been suggested that the LPS/endotoxin of S. hyodysenteriae may 
augment natural killer (NK) cell activity and immunosuppression in some tissues 
(23). Work with the mouse model has demonstrated differential susceptibility to 
disease based on LPS sensitivity. Lipopolysaccharide hyporesponsive mice are 
more refractive to the development of cecal lesions than LPS normal responder 
mice upon infection with S. hyodysenteriae. However, at challange doses of 
1 x I ()6 S. hyodysenteriae or greater, even LPS hyporesponsive mice (C3H/HeJ) 
develop lesions (78, 83). Due to these traits, LPS has been implicated in 
participating in inflammation during the course of disease by inducing the release 
of Jymphokines, prostaglandins and histamine from infiltrating cells (47). 
However, when compared to the LPS of nonpathogenic S. innocens, it has not 
been conclusively proven that the difference in virulence between the two 
bacteria lies in the biologic activity associated with the the LPS or endotoxin 
moiety (22). 
Enzymes cannot be discounted as possible virulence mechanisms of S. 
hyodysenteriae. This is not an area that has received much study. However, it 
has been shown that S. hyodysenteriae in the utilization of minute amounts of 
oxygen produces the enzymes NADH oxidase and superoxide dismutase (100). 
The role of these two enzymes has not been investigated in relation to the 
pathogenesis of swine dysentery. 
Motility almost certainly plays a significant role in the development of 
disease. As stated above, S. hyodysenteriae moves swiftly and efficiently 
through mucus. This characteristic may make the bacteria more difficult to 
phagocytize and to eliminate from the gut by excess mucoid secretions. This is 
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also an area that has recieved minimal attention. 
The progression of swine dysentery, though, is much more complex than 
one or two significantly toxic products from a bacterial species destroying tissue. 
Also implicated in the induction of swine dysentery are other general groups of 
bacteria, an inappropriate host immune response, environmental stresses, diet, 
and genetic predisposition towards susceptibility. 
One of the early pathologic responses seen in conventional swine 
following colonization of S. hyodysenteriae is an increase in mucus secretion 
from goblet cells in the basilar crypts of the large intestine (119). This is 
accompanied by coagulative necrosis of the mucosa! epithelium and the 
superficial lamina propria. Such areas are associated with large numbers of 
spirochetes (34). Also initially observed in infection by scanning electron 
microscopy is a rough, corrugated appearance of the cecal and colonic mucosa 
(107). Plus, superficial vascular congestion in cecal and colonic lesions and 
edema of the lamina propria have been demonstrated (1). As the disease 
progresses, crypt dilatation ( 4 7), separation of epithelial cells in the crypt 
shoulders (1), mucosa! hemorrhage (29), fibrin thrombi within superficial lamina 
proprial vessels (34), hepatic congestion (29), and eroded gut surfaces (34) are 
observed. Covering the eroded gut are pseudomembranes consisting of mucus, 
erythrocytes, bacteria and fibrin (34). Polymorphonuclear cells infiltrating under 
the eroded surface and mononuclear cells infiltrating into the lamina propria and 
submucosa also occur at this time (34). Primarily at this point the clinical signs 
of swine dysentery are exhibited. Serpulina hydysenteriae has been observed to 
be present within and between epithelial cells of the large intestine, but not 
beyond the lamina propria. However, tissue invasion is not believed to be a 
10 
necessary requirement for lesion development (1, 48, 108). It has not been 
conclusively proven whether or not receptor/ligand attatchment of S. 
hyodysenteriae to enterocytes is prerequisite to lesion progression ( 4, 37, 48). 
Similarly, mice infected with S. hyodysenteriae show mucoid feces, hyperemia 
of the cecal and colonic mucosa, varying incidence of cecal petechial 
hemorrhage, plus cecal mucosal edema, dilatation of crypt areas, and multifocal 
epithelial erosions (41). In addition, studies with mice have indicated that mast 
cells do not play a role in the pathogenesis of the disease affected by S. 
hyodysenteriae (77). Enlarged local lymph nodes often accompany infection 
both in pigs and in mice (29, personal observation). 
Ultimately diarrhea resulting from S. hyodysenteriae is due to colonic 
malabsorbtion. This occurs because of the failure of the epithelial transport 
mechanisms to move sodium and chlorine from lumen to blood. Also, responses 
of cyclic adenosine monophosphate (cAMP) and cyclic guanosine 
monophosphate (cGMP) are altered. This evidence indicates swine dysentery's 
pathogenesis is not similar to that of enterotoxigenic Escherichia coli or 
Salmonella spp. (29). Most animals die of dehydration, acidosis, and 
hyperkalemia (29). 
Gnotobiotic animals are often used to study diseases where pre-existing 
microflora may have varied and controversial effects on the pathogenesis. Swine 
dysentery is such a disease. Serpulina hyodysenteriae has been monoassociated 
(being the only microorganism present) or biassociated (being one of only two 
microorganisms present) with gnotobiotic pigs or mice (28, 30, 44, 70, 71, 76, 
79, 114). Swine monoassociated with S. hyodysenteriae show the organsim 
invading goblet cells as early as two days post infection and adjacent enterocytes 
1 l 
being invaded by the fourth day. This was accompanied with mucus 
hypersecretion and hyperplasia of immature basilar crypt cells. In addition, 
minor mucosa! erosion, but little inflammation, was observed in this model (79). 
When selected gram negative or gram positive microorganisms are biassociated 
with S. hyodysenteriae in the gnotobiotic pig or mouse model , disease follows. 
Initially four anaerobes were demonstrated to affect clinical disease when 
biassociated with S. hyodysenteriae in gnotobiotic pigs. Though not 
characterized, these bacteria were likely bacteroides and/or fusobacteria (70, 71, 
79) . In fact, high numbers of Bacteriodes vulgatus and Fusobacterium 
necrophorum have been found in the colonic mucosa of conventional swine 
during the initial stages of swine dysentery (2). Subsequently, Fusobacterium 
necrophorum, Bacteroides vulgatus, a Clostridium species, or listeria 
denitrificans biassociated with S. hyodysenteriae have been shown to facilitate 
the induction of dysenteric lesions in gnotobiotic swine (28, 114). None of the 
above mentioned organisms affected disease when monoassociated. Clinical 
signs were similar regardless of the secondary bacteria with which S. 
hyodysenteriae was co-infected. It has been suggested that the secondary 
bacteria may assist S. hyodysenteriae in growing to greater numbers in the 
intestine ( 114). Despite the reports of indicating the need for a second bacterial 
species in the development of swine dysentery (28, 44, 69, 114), there has been 
one report of monoassociated gnotobiotic pigs showing signs of disease (115). 
Gnotobiotic mice, also, have not exhibited lesions when monoassociated with S. 
hyodysenteriae, but have been shown to develop lesions when biassociated with 
S. hyodysenteriae and either Bacteroides vulgatus or Bacteriodes uni!Ormis (30, 
44, 76). These experiments indicate a synergistic role of existing microflora in 
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the development of swine dysentery (69) . Serpulina hyodysenteriae, however, 
still appears to be the sole etiologic agent associated with every naturally 
occurring outbreak in pig herds. 
Stress is another important factor in the development of swine dysentery. 
Different stressors include change in feed, overcrowding, castration, handling, 
transportation, other infectious diseases, and exposure to extreme temperatures 
(29). When stressed, carrier animals become more likely to develop clinical 
signs of disease. 
Additionally, diet seems to affect the development of disease. ln pigs a 
higher fibre diet decreases the likelyhood of disease (29). On the other hand, an 
egg-white-based diet in mice increases the susceptibility of S. hyodysenteriae 
affected cecitis. This increased susceptibility was accompanied by increased 
numbers of gram negative and gram postive organisms in the gut (78). 
Genetic background has also been shown to affect susceptibility of mice 
to S. hyodysenteriae induced cecitis. Lipopolysaccharide responsiveness, as 
described above, and specific mouse strain are known factors in disease 
development (78, 104). Presumably, genetic background would affect swine 
susceptibility, also, to swine dysentery. 
If a pig is multiply exposed to S. hyodysenteriae, increased, often 
sereotype specific, resistance is seen to redevelopment of swine dysentery, but 
not complete protection (42, 47, 86). This lack of protective immunity is not 
well understood. Various methods have been used to demonstrate specific 
immune responses to S. hyodysenteriae in the pig and mouse which include 
microtitration agglutination and in vitro growth inhibition of S. hyodysenteriae, 
both performed using convalescent serum (18, 29). Specific immunity is also 
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seen lactogenically with piglets (29). However, the majority of experiments 
showing specific immune responses to S. hyodysenteriae have utilized either the 
enzyme linked immunosorbant assay (ELISA) technique or the western 
immunoblot technique. 
A rise in specific immunoglobulin M (lgM), IgG , and IgA has been 
observed in mice and pigs exposed to S. hyodysenteriae in both the serum and 
intestinal secretions (90, 122). A rise in the titre of specific IgA, the major 
immunoglobulin at mucosal surfaces, has not been shown to correlate with 
protection against swine dysentery. Rather, increased levels of S. hyodysenteriae 
specific lgA reflects recent exposure to the bacteria (90). Paradoxically, specific 
IgA levels in gut secretions were demonstrated to be higher in swine during 
primary infection than during tertiary infection with S. hyodysenteriae (90). 
Further, it has been demonstrated that the colonic lamina propria of swine is a 
site for specific lgM and lgA production while the colonic lymph nodes are sites 
for specific lgG and lgA production. Systemically, lgG is the major antibody 
present. Conflicting reports exist pertaining to the correlation of specific IgG 
titres to protection against swine dysentery. Rees et. al. (90) have reported 
specific lgG titre to be related to prolonged exposure to S. hyodysenteriae and 
not protection. However, Wright et. al. (122) reported higher specific IgG titres 
in S. hyodysenteriae infected swine showing no clincal signs of swine dysentery 
as opposed to swine with clinical signs. Convalescent swine sera has also been 
shown to have anti-S. hyodysenateriae LPS antibody that affects opsonization 
and partial disease protection in a strain specific manner (82). This strain 
specific anti-LPS antibody is routinely used to separate S. hyodysenteriae isolates 
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into serotypes and serogroups (29, 65). To date, at least nine serogroups have 
been demonstrated many of which contain different serotypes (26, 59, 60). 
The western immunoblot technique has been used extensively in the 
characterization of the humoral immune response of mice and swine to 
S. hyodysenteriae. Much of the antibody response seen using this method is 
cross-reactive with S. innocens (79, 47). However, three cell antigens at 31, 36, 
and 68 kDa were found to be specific for S. hyodysenteriae by western 
immunoblot using hyperimmune rabbit serum raised against S. hyodysenteriae 
( 10). Additionally, as shown by western immunoblot, cellular antigens with 
molecular weights from 29 to 45 kDa were conserved between different 
serotypes of S. hyodysenteriae using sera from convalescent or vaccination 
protected pigs (10, 56). This is in contrast to cellular antigens with molecular 
weights from 14 to 24 kDa which differed between strains when hyperimmune 
rabbit serum raised against S. hyodysenteriae was used in the immunoblot (10). 
The conserved bands were probably components of the flagella (56, 52) and the 
nonconserved associated with the LPS (10). Both flagellar and LPS antigen are 
associated with the cell envelope of S. hyodysenteriae which has been shown 
through immune elecron microscopy to contain the major antigens recognized on 
western immunoblots (113). Therefore, the outer membrane has been separately 
characterized through western immunoblot. Protein antigens were found ranging 
in sized from 14 kDa to over 100 kDa (47, 113). A band at 16 kDa has been 
demonstrated as species specific for S. hyodysenteriae and endotoxin- or LPS-
1 ike in character as shown by loss of immunoblot activity when convalescent pig 
serum was absorbed with S. hyodysenteriae endotoxin (113). The 16 kDa 
antigen has also been shown to have antibactericidal activity to S. hyodysenteriae 
' 
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in vitro and has been found in sera and colonic secretions of convalescent swine. 
This indicates a possible importance in stimulating a protective immune response 
(97). When cell components were treated with metaperiodate or proteinase K, 
loss of the 14-19 kDa band was demonstrated on immunoblots only with the 
metaperiodate treated preparation. This would indicate that the species specific 
antigen has carbohydrate and/or lipid moieties (47, 113). The gene encoding the 
16 k.Da molecule has been identified and termed smpA (109). In addition, a 
unique 45 kDa antigen has also been demonstrated in the outer membrane of two 
S. hyodysenteriae strains, P18A and MLC52/80 (97). Despite the above 
demonstrated specific immune responses, it has been hypothesized that resistance 
also requires a low level chronic colonization with S. hyodysenteriae (42). A 
better understanding of the immune response to S. hyodysenteriae may explain its 
largely ineffective protective qualities for feeder pigs. 
Mucosal Immune System 
The immune system response occurs at different sites where, first, 
antigen is encountered and initial responses occur (inductive sites), second, the 
physical path activated cells follow while proliferating and differentiating, and 
third, sites where mature, stimulated, fully differentiated immune cells are found 
(effector sites) (67). The signals received in these three steps are a complex 
network that in great part defines the immune response. 
Because S. hyodysenteriae doesn't invade beyond the lamina propria, 
most of the specific immune response, theoretically, would be stimulated via the 
mucosa] route. Antigen mainly, though not exclusively, exits the gut through 
dome cells also called microfold (M) cells or follicle-associated epithelial (FAE) 
cells. These cover the gut associated lymphoid tissue (GALT) termed Peyer's 
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patches. The dome cells have short microvilli , smaJl cytoplasmic vesicles, and 
few lysosomes. They can easily transport lumenaJ antigens such as proteins and 
particulates like bacteria, viruses and smaJl parasites via nondenaturing 
pinocytosis (67, 92, 110). 
Once in the Peyer' s patches, the antigen acts in its unmodified form as 
the first of two signaJs to stimulate mature, specific B lymphocytes by binding to 
membrane bound immunoglobulin (lg) receptors. The majority of these B cells 
are located in germinaJ centers of distinct follicles. Switching to the lgA isotype 
and affinity maturation are considered to occur at this site, but significant 
numbers of plasma cells do not develop in the Peyer' s patches (67) . Adjacent to 
the follicles are areas containing mature T lymphocytes. These cells contain the 
pan T cell marker, CD3, and have T cell receptors (TCR) mainly of the ap 
pheotype (95%). This T cell population is also characterized by CD4+ Co8-, 
CD4-CD8 + , and CD4-CD8- subsets (67). In addition, accessory cells are 
present in the Peyer' s patches, namely major histocompatabiJity antigen (MHC) 
class u + B cells, dendritic cells, and macrophages (67). These cells present 
partially degraded antigen associated with MHC class II antigen to act as the first 
of two activation signaJs for specific T lymphocytes. These two molecules 
interact with CD3, TCR, and CD4 markers on the target T lymphocyte (67). 
This T cell antigen recognition is probably more limited than B cell antigen 
recognition and represents sites uni.que from those bound by B cells. T cell 
recognized antigens are often "unfolded" portions of protein with which B cells 
don't naturaJ 1 y have con tact ( 17). 
The antigen presenting cells can also provide lymphokines, namely 
interleukin-l(IL-1) from macrophages, that function as the second activation 
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signal for T cells. This is particularily effective in the presence of suboptimal 
mitogen levels ( 17). As stated above, IL-1 is a proinflammatory cytokine. It 
has been shown to affect fever, release of neutrophils from the bone marrow, 
elevation of acute phase reactants, and lowering of plasma iron and zinc 
concentrations (17). The activated T cells, in tum, secrete lymphokines that 
autostimulate such as IL-2 (17) and act as the second activation signal for B cells 
such as IL-2, IL-4, and transforming growth factor beta (TGF-~) (17, 67). 
Interleukin-2 is essential for T cell proliferation, differentiation, and clonal 
expansion ( 17). 
Upon original exposure to an antigen, IgM is produced. Later, with 
continued antigen exposure or antigen re-exposure, an isotype switch occurs 
resulting in IgG, lgA, or lgE phenotype. The antibodies also become more 
specific for the stimulating antigen(s) through a process referred to as affinity 
maturation. Affinity maturation is due to somatic point mutations in the 
immuoglobulin variable region genes (89). Such activities occur before the 
plasma cell (terminal antibody secreting cell) stage and are often attributed to 
memory B cells. Whether or not T cells go through an analogous process has 
not been demonstrated. However, preferential expansion of different T cell 
subsets has been observed. Switch T cells, cells that cause a change in antibody 
isotype, that are specific for IgA have been demonstrated in the Peyer' s patches 
(17). These differ from switch T cells found in the spleen which upon 
stimulation with concanavalin-A supressed IgA synthesis (6, 67). Switch T cells 
appear to be auto reactive and triggered directly by MHC class II determinants 
(6). The switch mechanism probably involves deletion and rearrangement of the 
heavy chain gene of B lymphocytes (110). Transforming growth factor-~ has 
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been implicated in the switch of lgM+ cells to IgA + cells (63) . Also, many 
other affects are attributed to TGF-p. These include inhibition of cytotoxic T 
cell generation, NK cell function, and T and B cell proliferation, monocyte 
chemotaxis, and suppression of IgG and IgM secretion (98, 11 2). However, 
switch T cells don't support terminal differentiation into IgA plasma cells (6, 
67). 
Post switch T helper (Th) cells favoring lgA production have been 
cloned from murine Peyer' s Patches (6). The presence of these post switch T 
cells is often accompanied by suppression of a systemic IgG reaction to the 
stimulating antigen(s) , also called oral tolerance (92). The phenomenon has been 
attributed to T suppressor (Ts) cells which leave the Peyer' s patches and seed 
peripheral tissues (110). Oral tolerance abrogation has, in fact, been seen when 
T contrasuppressor (Tes) cells are passively transferred to tolerized mice (110). 
Immunolglobulin A binding factor has also been implicated in oral tolerance 
induction (110). Oral tolerance may be a protective response of the host against 
harmful systemic reactions elicited by IgG, lgE, and T cell mediated delayed 
type hypersensitivity (6). There is evidence that oral tolerance may also be 
abrogated by abnormal expression of MHC class II antigens on epithelial cells. 
This may cause preferential activation of CD4 + T cells instead of cog+ T cells. 
Such a situation was observed when T cells were exposed to colonic epithelial 
cells from patients with inflammatory bowel disease (lBD) (6) . 
Due to the actions of Th, Ts, and Tes cells present in the Peyer' s 
patches, initially stimulated B lymphocytes will begin proliferating and 
differentiating into the dimeric IgA-secreting cells found at mucosal sites (110). 
Once specific lymphocytes are activated, they move out of the Peyer' s patches 
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via the efferent lymphatics and move into the blood stream through the thoracic 
duct (67). The cells then progress to the spleen where they probably receive 
additional developmental signals; they then migrate back to mucosa! sites and 
mucosa) associated lymph nodes including the lamina propria of the respiratory , 
gastrointestinal (Gt) and reproductive tract, and mammary, salivary and lacrimal 
glands where more developmental signals are likely received (lL-5, IL-6, 
interferon gamma (lNF--y), TNF, additional antigen stimulation) (67). Specific 
IgA antibody-forming cells have been observed transiently in peripheral blood 
mononuclear cells at 7-12 days post oral immunization and their presence 
preceded the appearance of specific secretory-IgA (S-IgA) antibodies in saliva 
and tears (67). It has been estimated that approximately eighty percent of 
immunoglobulin producing cells are located in the intestinal mucosa alone (6). 
Switch T cells have receptors for the Fe (FcR) portion of IgA. Other 
nonswitch T cell bear FcR for IgA, too. It is likely such cells play a role in 
isotype regulation (17). There is evidence that IgA binding factor secreted from 
T cell hybridomas stimulates IgA responses at low doses and inhibits at high 
doses (17). Another factor in the development of IgA antibody secreting cells 
(ASC) are the ratios and levels of CD4 versus CD8 postive cells and Thi versus 
Th2 cells. The former are differentiated by their receptor expression and latter 
are differentiated on their cytok:ine secretion profiles. 
T cells expressing CD4 and CD8 markers interact with MHC class II 
and class I antigens, respectively ( 17). Cells that are CD4 + demonstrate mainly 
helper cell functions such as supporting antibody secretion or expansion of other 
T cell populations. Cells that are cog+ usually exhibit cytotoxic or suppressor 
functions (67). 
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T helper 1 cells typically secrete IL-2, IL-3, IFN-'Y, and TNF-~. 
lnterleukin-3 is a differentiation factor for immature T-cells and it serves as a 
growth factor for murine basophils and mast cells (15). lnterferon-'Y has a wide 
range of effects which includes loca1 and systemic antiviral effects, cellular 
differentiation, growth, surface antigen expression, morphology, 
immunoregulation, cell mediated immunity, augmentation of natural killer cell 
activity, activation of macrophages for tumoricida1 and bacteriocidal activ-ity, and 
induction of lL-2 receptors and T cells effects (17). T helper I cells have been 
implicated in cell-mediated immunity by secreting cytokines that activate 
macrophages to more effective killing of intracellular bacteria (67). 
T helper 2 cells typically secrete IL-3, IL-4, IL-5, IL-6, and IL-10 (63, 
115). There has been shown to be higher levels of Th2 cells in mucosa 
associated tissues which may in tum support IgA production (57, 67). 
lnterleukin-4 alone affects LPS activated mouse spleen cells to switch 
isotype to lgGl or IgE (63). This lymphok:ine is a B cell growth factor which 
stimulates activated B lymphocytes to proliferate (9). lnterleukin-4 can also up-
regulate MHC class ll expression on B cells (56). 
lnterleukin-5 will synergize with several different lymphokines for IgA 
production (57). Transforming growth factor-~ has been shown to act in 
conjunction with IL-5 to cause lgA production additively in LPS stimulated B 
cell cultures (98). In this same system, IL-2, in place of IL-5, was found to 
have a synergistic effect on IgA production (98). There is also evidence that the 
presence of IL-5 suppresses the production of antibody isotypes other than lgA 
(98). Interleukin-5 has been shown to increase numbers of IgA secreting cells 
and to induce actua1 secretion, but not ce1l division in culture (6, 67). 
21 
fnterleukin-4 in conjunction with IL-5 has been shown to enhance IgA secretion 
in splenic B cells. In this situation IL-4 probably acted as a switch factor (98, 
110). With Peyer's patch cells, IL-5 and IL-6, but not IL-4 seem to affect lgA 
synthesis. lnterleukin-5 also up-regulates IL-2 receptors on B cells further 
indicating a role for IL-2 in lgA synthesis (110). 
Interleukin-6 is a potent cytokine in conjunction with IL-5, as indicated 
above, in conjunction with other factors, and separately. It has been shown that 
IL-6 acts with IL-1 to promote IgM secretion and with IL-5 to promote IgA 
secretion in Peyer' s patch B cells in a synergistic manner (57). Interleukin-6 is 
considered to be a relatively late-acting lymphokine while IL- 1 and IL-5 are 
considered to be early-acting lymphokines. Interleukin-6 can also act to induce 
synthesis of acute phase proteins in liver cells, induce the central nervous system 
(CNS) to cause neuronal differentiation and to induce fever (57). Interleukin-6 
may have an autocrine effect since it is also produced by plasma cells. 
Additionally, macrophages, fibroblasts, endothelial cells, and epithelial cells 
produce IL-6 (57, 65, I IO). Interleukin-6 has also been found to act on T cells 
in concert with other stimuli to induce IL-2 production (57). Interleukin-6 is a 
potent cofactor in mitogen-induced T cell proliferation and can enhance the 
cytolytic T cell differentiation in the presence of IL-2 (57). The above 
observations, then , may represent a step wise stimulation of B cells by different 
lymphokines for antibody secretion (57). Alternately, lL-6 may simply cause an 
increase in the number of cells secreting IgA via proliferation (57). 
Interleukin- IO production has been reported in mice during parasitic 
infection. The presence of IL- 10 is often accompanied by INF4 suppression 
(73). Interleukin-IO has also been shown to inhibit production of IL-1, IL-6, 
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and TNF-cx. while up-regulating expression of MHC class II molecules on B 
cells. In addition to T cells, B cells, macrophages, and keratinocytes have also 
been demonstrated to secrete IL-10 (56). 
Different phenotypic characteristics between systemic immune sites, 
bronchus associated lymphoid tissue (BALT), and GALT have been implicated 
in, and may be partially explained by, the different cell populations and 
microenvironments found (6). It has been suggested that Ia+ antigen on 
epithelial cells increases the number of CD8 + cells as opposed to antigen 
presented by monocytes to CD4 + cells and may make the difference between 
tolerance and responsiveness, respectively (110). 
In the lamina propria of the gut, IL-5 + cells have been shown to out 
numbere INPy+ cells by two or three times as opposed to Peyer' s patch T cells 
where less total cytokine-producing cell numbers were present and the IL-5+ and 
INPy+ cells were equal in number (67). The same ratios were seen with 
intraepithelial lymphocytes (IEL) as in the Peyer' s patches except that at least 
some of the IL-5 and INF-'Y secretion was due to CD8 positive cells (67). 
Additionally, it may be that mucosa associated lymphoid tissue (MALT) 
preferentially attracts and activates T cells secreting IL-5 (6). Secondary signals 
for terminal differentiation into lg-producing plasma cells have been implicated 
to be provided at final secretory tissue sites (6). It has been further suggested 
that HLA-DR determinants not only of lamina proprial dendritic cells, but also 
on epithelial may contribute to B cell differentiation (6). 
Once activated, the specific homing of committed immune cells to 
mucosal sites has been attributed to cell surface markers both on lymphocytes 
(homing receptors) and high endothelial venules (HEY) (addressins) adjacent to 
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mucosa! sites. Different markers have been implicated to serve the same 
function for peripheral lymphoid tissue (38, 110). In humans, lymphocyte 
function-associated antigen I (LFA-1) and very late activation antigen-4 (VLA-4) 
are two mucosal homing receptors and intercellular adhesion molecules (ICAM-1 
and ICAM-2) are two possible complementary addressins for LFA- 1 at the 
mucosa] sites. Similarily, vascular cell adhesion molecule- I (VCAM-1) may 
serve as the addressin for VLA-4. During inflammation, ICAM- 1, VCAM- 1 
and endothelial leukocyte adhesion molecule- I (ELAM-1) , another addressin, 
have their surface expression up-regulated (38). 
Bacterial LPS/endotoxin is a substance that has an immunomodulatory 
effect on lymphocytes and, therefore, regulatory cells ( 110). Its presence can 
cause an increase in local cytokine levels and expression of surface activation 
markers (3, 6). At the gut surface where so many bacteria reside LPS's effects 
on immune responses play an important role. 
In the gut, the B cells and CD4 + T cells are mainly in the Lamina 
propria (6, 17). In swine the largest population of plasma cells was found to 
reside in the lamina propria of the intestinal tract for IgM, IgG, and lgA 
isotypes. The porcine spleen and mesenteric lymph nodes were thought to play a 
minor role in immunolglobulin synthesis (7). Secreted pentameric IgM or 
dimeric lgA is assembled in plasma cells with an associated J-chain then it is 
transported from the basolateral surface of epithelial cells to their mucosal 
surface via the secretory component receptor in vessicles. In the pig lgA and 
IgM are, in fact, found in intestinal crypt epithelial cells indicating a similar 
intracellular secretion pathway (7). When the multimer is released into the gut 
lumen, part of the secretory component remains to anchor the complex into the 
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mucus layer and to protect against degradation (92, 110). Interferon gamma and 
TNF-cx. have been implicated in up-regulation of the membrane expression of 
functional secretory component (6, 110). Secretory lg-A represents over eighty 
percent of the antibody produced in mucosa associated tissues (67). 
The presence of IgA has the potential to cause neutrophil accumulation. 
The subsequent neutrophils are destroyed and release lactoferin, lysozyme, and 
cationic proteins which may contribute to immunity against bacteria (92). 
Immunoglobulin-A also has the affect of neutralizing virus before it crosses the 
mucosa.I barrier. Immunoglobulin-A can inhibit adherence of some bacteria to 
the mucosa! epithelium by specific and nonspecific binding. Bacteria covered 
with IgA are at a survival disadvantage in the highly competitive 
microenvironment of the gut. Continuous desquamation of epithelial cells also 
plays a protective role against pathogenic bacterial colonization (67). The 
lactoferrin and lactoperoxidase systems that act against several mucosa! 
pathogens are enhanced by the presence of IgA. Immunoglobulin-A can also act 
with CD3 + CD4 + Leu8 + T cells to affect antibody dependent cell cytotoxicity 
(ADCC) against Salmonella and Shigella species. In fact, such T cells can be 
seen to increase in individuals orally immunized with a Salmonella vaccine. 
Immunoglobulin A can act to immune exclude antigens that the host has already 
been exposed to and, owing to its reduced ability to activate the complement 
cascade as compared to IgG or IgE, reduce the likelyhood of a severe 
anaphylactic or inflammatory reaction (67). However, some bacteria can 
degrade IgA then use the resulting Fab portion for coating which affects 
protection from the destructive action of other antibodies ( 110). 
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The classical view of IEL populations states that T lymphocytes (mainly 
CD8 +) home to mucosa! epithelium. They mainly exhibit cytotoxic activity, 
contain a high percentage of yo TCR' s, and may not require thymic processing 
(6, 12, 92) . With age, MHC class II (Ia) expression is increased. Along with 
increased Ia antigen expression by enterocytes, comes increased numbers of 
IEL's (17). However, there is evidence that T cell populations between the 
small and large intestine vary significantly. Small intestine IEL's fit more the 
classical description, while large intestine IEL's do not. The IEL's present in the 
large intestine have been shown in mice to be less cytolytic and to contain 
homing receptors like L-selectin which is a traditional lymph node homing 
receptor (8). 
What exact developmental pathway a cell takes depends on its 
microenvironment and includes site of activation. It has also been shown that 
significant numbers of IgA plasma cells in the murine GI tract are derived from 
self-renewing Ly-1 + (CD5 +) B cells which reside in the peritoneal cavity. 
These B cells have been shown to be the origin of serum IgM against naturally 
occurring antigens and some autoantigens. It is not known if B cells from the 
Peyer' s patches contribute to this population or not. It has also been postulated 
that CD5 + B cells represent memory cells (67). 
Additionally, memory T cells have been demonstrated in the lamina 
propria of humans. These cells showed a high expression of CD45RO marker, a 
typical characteristic of systemic memory T cells. However, these cells differed 
from systemic memory T cells in that they did not show a high expression of 
CD29 and they directly secreted B cell helper factors ( 124). 
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As stated above, IgA is not the only immunoglobulin isotype synthesized 
during swine dysentery. However, IgG production may, at least in part, be 
generated by direct contact of antigen with blood cells. Any IgG present in the 
gut lumen, also, comes from the blood. Its presence may augment inflammation 
via the complement cascade. This cascade could also be activated via the 
alternative pathway with blood contacting certain key organisms in the 
microtlora. Release of C5a, C3a, and C4a with complement activation causes 
smooth muscle contraction, vascular permeability, and chemotactic influx of 
phagocytic cells and other leukocytes. Both IgG and IgA can also act as 
opsonization factors , particularity in the presence of C3 and C4 on the same 
cells. Fibronectin, a serum protein, can also affect opsonization in the presence 
of another opsonin. There is also evidence that activated complement receptors 
on B lymphocytes may cause them to proliferate and mature into plasma cells. 
In vitro C3a and C5a have antagonistic effects on antibody secretion and 
lymphocyte proliferation with C5a enhancing the two events. Also, complement 
activation has been suggested to be important in lymphocyte memory (72). 
Mast cells may also play a significant role in inflammation. Cells 
susceptible to the often proinflammatory or anaphylactic signals of mast cells 
include lymphocytes, macrophages, neutrophils, eosinophils , platelets, bone 
marrow stem cells, smooth muscle cells, goblet cells, and neurons ( 17). 
However, as stated above, mast cells do not likely play a significant role in the 
pathogenesis of swine dysentery. 
Cytotoxicity is another important protective immune response 
demonstrated by certain lymphocytes and is important in combatting viral 
infections and eliminating transformed cells (17, 67). It can either be due to 
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antibody dependent cell cytotoxicity (ADCC), defined receptor/ligand 
interactions such as MHC class I antigen with viral antigen contacting the CD3, 
TCR, and CD8 markers of cytotoxic T cells or undefined receptor/ligand 
interactions such as that seen with natural killer cells. Natural killer cells are 
large lymphocytes containing azurophilic cytoplasmic granules and are not Tor 
B cells ( 17). In addition to direct killing of cells, NK cells may play a role in 
stem cell development and immunoglobulin regulation. There is also evidence 
that NK cells can be inhibited by the inflammatory process (17). 
Another important consideration in the mucosa) immune response is 
what occurs upon a break in the epithelium. The following process has been 
outlined. When there is a break, undue stimulation of antigen presenting cells 
(APC) and/or enhanced epithelial expression of MHC class II determinants 
occurs. These events are followed by increased presentation of lurninal antigens 
and general overstimulation of CD4 + cells. This can cause increased production 
of dimeric IgA, excessive IgG and lgE responses, and delayed type 
hypersensitivity (6). 
In swine dysentery, lymphocytic cells accumulate and are specific, but 
not very protective. Different medications are effective in eliminating S. 
hyodysenteriae from pigs. These include tiamulin, lincomycin and carbadox 
given in water (29). However, immunization attempts either parenterally or 
orally with naive swine using inactivated S. hyodysenteriae or attenuated strains 
have had little or no success in generating a protective immune response (21 , 32, 
33). With the exception of a report showing protection with a cloned flagellar 
fragment, minimal vaccination effectiveness has also been seen in the mouse 
model (5). However, another report found no correlation between vaccination 
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with a flagellar protein and protection in the mouse from S. hyodysenteriae 
induced cecitis ( 19). 
Found to be a factor in many inflammatory diseases, though not always 
representative of recovery from disease, is a rise in antibody production 
systemically and/or locally. Adult periodontis is such a disease where a large 
number of local specific plasma cells are seen against Porphyrmonas gingivalis, 
but recovery from disease is not related to these numbers. Rather, chronic 
inflammation with associated host tissue destruction is seen (84, 85). Rotavirus 
infection is another inflammatory disease where local specific ASC have been 
demonstrated (68). An increase in nonspecific plasma cells in the intestine, 
particularily IgG positive cells, is seen in inflammatory bowel disease (IBD), a 
general category of chronic intestinal inflammation including Crohn' s disease and 
ulcerative colitis ( 123). 
Cholera Tuxin 
It may be possible that not a great enough or an appropriate immune 
response can be generated either parenterally or without oral adjuvants against S. 
hyodysenteriae for protection against swine dysentery. Several different 
adjuvants have been used orally with other diseases including biodegradable 
microspheres, cholera toxin and heat labile toxin of enterotoxic E.coli (58, 63). 
Also, selective delivery of protective antigens has been attempted using 
recombinant bacteria (67). 
Cholera toxin is one of the most frequently used oral adjuvants. It 
consists of five B subunits and one A subunit. The B subunits bind to 
monoasialoganglioside, GMl, present on all nucleated cells. This binding causes 
a conformational change that allows the A subunit to penetrate into the cell and 
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disrupt the cAMP cycle (67). Cholera toxin in microgram amounts will induce 
an antibody response to itself consisting of specific S-IgA and serum IgG both 
which originate in the GALT. Cholera toxin and its B subunit do not induce oral 
tolerance. Oral immunization with cholera toxin also results in prolonged 
memory in the intestinal lamina propria (67). Cholera toxin is not a typical 
adjuvant because it stimulates an immune response against itself; however, this 
trait may be what allows cholera toxin to be used as an adjuvant (67). Cholera 
toxin may provide the appropriate signals that alter the regulatory environment of 
the GALT from suppression to responsiveness (67). Cholera toxin may also 
stimulate Th2 cells in the gut and supress Thl cells (121) which would ultimately 
lead to the expansion of T cel1 subsets supporting B celJ proliferation and 
differentiation. Additionally, cholera toxin 's adjuvanticity may be a fairly 
complex event involving increased uptake of antigen into mucosa] follicles , 
enhancement of IL-1 production by APC's, altered regulation by T cells, 
inhibition of COS + suppressor cells, stimulation of B cell switching to IgA and 
IgG positive cells, and possible enhancement of B cell clonal expansion (67). 
Cholera toxin plus keyhole limpet haemocyanin (KLH) has been shown 
to enhance KLH sensitivity upon re-exposure in the spleen, mesenteric lymph 
nodes (MLN), lamina propria, and Peyer's patch lymphocyte populations as 
evidenced by proliferation of CD4 + and CDS+ cells and their production of IL-
2 and IL-4 (11). Cholera toxin plus a streptococcal antigen has evoked 
substantial specific antibody responses in the MLN, spleen, salivary glands, and 
serum (14). Ovalbumin conjugated to cholera toxin and presented to the 
intestinal mucosa also shows an enhanced antibody responses in the lamina 
propria of mice (31). However, cholera toxin does not just stimulate the 
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immune system. It can have more practical application. Cholera toxin 
conjugated to noninfectious Sendai virus given orally to mice then given as an 
intranasal booster conferred protection. This was directly related to virus 
specific titres of IgA in nasa1 secretions (61). Oral immunization with cholera 
toxin and tetanus toxoid was a1so shown to protect experimental mice against a 
later norma1ly lethal dose of tetanus toxoid. This effect was attributed to 
neutralizing systemic antibodies (36). The above antigens can not achieve the 
same level of immune stimulation seen when administered without chol.era toxin. 
It has a1so been suggested that the ability of certain antigens to bind to intestina1 
epithelium may dictate the strengh of the antibody response ellicited by cholera 
toxin adjuvant. In other words, strong immunogens in the presence of cholera 
toxin are weak tolerogens in its absense and vice versa ( l 11 ). Thus, exploration 
into the effects of ora1 adjuvants against the development of swine dysentery 
a1ong with a better understanding of immune events in the gut could prove useful 
in future generation of an effective vaccine. 
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PAPER: CHARACTERIZATION OF THE MURlNE B LYMPHOCYTE 
RESPONSE TO SERPULINA HYODYSENTERlAE FOLLOWING ORAL 
IMMUNIZATION AND CHALLENGE 
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ABSTRACT 
Using the ELISPOT technique, antibody secreting cell (ASC) responses 
to antigens of Serpulina hyodysenteriae were explored. Mice were either 
parenterally or orally immunized with a cellular lysate of S. hyodysenteriae. 
Orally immunized mice received 500 µg of the spirochetal lysate with cholera 
toxin as an adjuvant or 1 mg of the spirochetal lysate alone. Subsequent 
infection of immunized mice with S. hyodysenteriae showed that oral 
immunization had primed for a greater specific systemic and mucosa! ASC 
response as compared to parenteral immunization. This was seen both at ten and 
17 days post infection. In addition , the use of cholera toxin as an adjuvant 
increased systemic IgA ASC' s at 17 days post infection. Using the ELISA 
technique, it was demonstrated that oral immunization effectively primed for 
both the serum IgG and lgA responses while parenteral immunization only 
primed for the serum IgG response. Even though oral immunization primed for 
specific immune response to S. hyodysenteriae, there was no correlation between 
the level , specificity, or isotype of the immune response and protection from 
disease. 
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INTRODUCTION 
The etiologic agent of swine dysentery is Serpulina hyodysenteriae, 
formerly Treponema hyodysenteriae (10, 54). Serpulina hyodysenteriae is a 
motile, gram negative spirochete that grows well in the presence of I % oxygen 
(52). 
Swine dysentery is a mucohemmorrhagic diarrheal disease affecting 
primarily, though not exclusively, feeder pigs (12). Annually, this disease has 
been estimated to cost the U.S. pork industry 180 million dollars (22) due to the 
monetary losses associated with morbidity and mortality (41). 
Pigs become infected with S. hyodysenteriae most commonly by 
ingesting feces from pigs that are currently shedding the bacteria. Asymptomatic 
pigs can shed S. hyodysenteriae as has been demonstrated by Joens et. al. ( 19). 
In addition, S. hyodysenteriae can be spread mechanically or exist in reservoir 
mouse populations (18). In the porcine large intestine, the site where S. 
hyodysenteriae causes lesions, the organism is chemotactically attracted to mucus 
and subsequently multiplies in the crypts of Lieberkuehn (23, 60, 61). 
Because mice can maintain a long term infection with S. hyodysenteriae and will 
show an accompanying cecitis, they are often used as a laboratory model for 
swine dysentery (18, 38). 
A hemolysin and the lipopolysaccharide (LPS) of S. hyodysenteriae have 
been implicated in the pathogenesis of swine dysentery (12, 22, 24, 25, 26, 41 , 
42, 43, 50, 51). However, it is likely that development of disease involves more 
than these two factors. Other bacteria, an inappropriate host immune response, 
environmental stresses, diet, and genetic background have also been implicated 
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in the development of or susceptibility to swine dysentery (9, 12, 17, 20, 21, 34, 
35, 40, 53). 
Pigs multiply exposed to S. hyodysenteriae show increased, often 
serotype specific, resistance to reinfection. Despite this, complete immunity to 
S. hyodysenteriae has not been demonstrated (l 9, 20, 46). 
A rise in antibody production systemically and/or locally has been 
reported for some mucosal inflammatory conditions. Adult periodontis is such a 
disease. Specific local and systemic antibody against Porphyromonas gingivalis 
has been demonstrated which does not correlate with recovery from disease (44, 
45). Inflammatory bowel disease (IBD) is another chronic inflammatory 
condition associated with a rise in local antibody production. An increase in the 
number of nonspecific plasma cells located in the human large intestine has been 
associated with the pathogenesis of IBD (64). A rise in local specific antibody 
secreting cells (ASC) has also been reported for rotavirus infections (32). 
During swine dysentery, S. hyodysenteriae specific lgM, IgG, and IgA 
have been demonstrated both in serum and intestinal secretions (48, 63). An 
increase in IgA, the major immunoglobulin at mucosal surfaces, has been 
reported to reflect recent exposure to S. hyodysenteriae, but has not been 
correlated with protection against disease (48). An increase in specific serum 
IgG has been reported to be related to prolonged exposure to S. hyodysenteriae 
(48). Relatively higher specific lgG titres have been demonstrated in 
asymptomatic, S. hyodysenteriae infected pigs as opposed to infected swine 
showing clinical disease (63). However, immunological prevention of the 
clinical symptoms of swine dysentery, in a predictable manner, has not been 
achieved. In general , vaccination either parenterally or orally of naive swine 
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with preparations of S. hyodysenteriae or with attenuated strains have had 
minimal success at inducing protection (8, 15, 16). A similar situation has been 
observed in mice with the exception of using cloned flagellar fragments. 
Immunization with these fragments may protect mice against S. hyodysenleriae 
induced cecitis (2, 7). 
Mucosal adjuvants may enhance the mucosa] immune response and 
protection from disease caused by mucosa] pathogens. Biodegradable 
microspheres, cholera toxin , and heat labile toxin of enterotox_igenic Escherichia 
coli have all been used as oral adjuvants (29). In other systems, cholera toxin 
has proven to enhance antibody production at mucosa! surfaces against poorly 
immunogenic proteins (6, 14). Cholera toxin in an inactivated Sendai virus 
immunization trial of mucosa} surfaces has been shown to enhance specific IgA 
that prevented infection by live Sendai virus (28). 
ln the following experiments, the ability of cholera toxin to enhance the 
immune response of mice to S. hyodysenteriae antigens was explored. This was 
accomplished by measuring specific ASC via the EUSPOT technique in 
mesenteric lymph nodes (MLN) and spleen of variously immunized and/or 
infected animals. Specific serum antibody levels were also determined using the 
EUSA technique and antibody specificity was determined using the western 
immunoblot technique. 
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MATERIALS AND METHODS 
Animals: The mice used were strain C3H/HeOuJ. These mice were 
obtained from a breeding colony maintained at the College of Veterinary 
Medicine, Iowa State University. Original breeders were purchased from 
Jackson Laboratories, Bar Harbor, Maine. 
Bacterial Strains: Serpulina hyodysenteriae B204 with less than 20 in 
vitro passages was grown anaerobically at 37°C in trypticase soy broth (BBL 
Microbiology Systems, Cockeysville, Md.) supplemented with 5% horse serum 
(HyClone Laboratories, Logan, Utah), 0.5 % yeast extract (BBL), and 1 % VPI 
salt solutions as previously described (58). Highly motile (motility, > 90%) log-
phase cultures were obtained by inoculating warm (37°C) broth with a 33% 
inoculum from an overnight culture and incubating the inoculated broth for 
approximately 5 h. Bacteria were enumerated by using a Petroff-Hauser 
counting chamber. 
Antigen Preparation: Serpulina hyodysenteriae B204 cells in log phase 
were collected by centrifugation. The cells were washed with 0.1 M phosphate 
buffered saline (PBS), pH 7.2, and suspended in a final volume of 10 ml. The 
cells were disrupted via sonication and the mixture was harvested by 
centrifugation (10,000 x g). The subsequent pellet was then assayed for total 
protein by the method of Lowry et. al. (30) and found to be 20%. For storage 
the lysate was lyophilized and stored at -200C. 
Vaccination Protocol: In Experiment One mice were either 
intraperitoneally (LP.) or orally (P.O.) immunized. Mice LP. immunized were 
injected with 300 µg S. hyodysenteriae B204 whole cell lysate in normal pyrogen 
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free saline on days one and 13. Mice P.O. immunized were orally intubated 
with a total of 500 µg of S. hyodysenteriae 8204 whole cell lysate, 30 µg of 
cholera toxin subunit B, and 1.5 µg of whole cholera toxin (62) in 0.1 M PBS, 
pH 7. 2, on days one, two, and three; this immunization was repeated on days 
13, 14, and 15. 
In Experiment Two, mice were either orally intubated with lmg of S. 
hyodysenteriae B204 whole cell lysate or orally intubated with 500 µg of S. 
hyodysenteriae B204 whole cell lysate, 30 µg of cholera toxin subunit B, and 1.5 
µg of whole cholera toxin (62) in 0.1 M PBS, pH 7.2. The above two 
vaccination protocols were performed over a period of three days (days one, 
two, and three) ; these immunizations were repeated on days 13, 14, and 15. 
ln Experiment Three, the mice were orally intubated with a total of 500 
µg of S. hyodysenteriae B204 whole cell lysate, 30 µg cholera toxin subunit B, 
and 1.5 µg of whole cholera toxin (62) in 0.1 M PBS, pH 7.2, on days one, 
two, and three; this immunization was repeated on days 13, 14, and 15. 
Infection Protocol: In all experiments vaccinated mice along with an 
unvaccinated group were infected with I x I 08 S. hyodysenteriae B204 orally on 
day 25. Three days prior to challenge all mice involved in the experiment were 
fed a Teklad 85420 Diet (Harlan Sprague Dawley) on which they remained for 
the duration of the experiment. Mice were sacrificed on day three, ten, 17, or 
30 post infection. Spleen, MLN, serum, and cecum were collected from each 
mouse. At the time of sacrifice, mice were between ten and 18 weeks of age. 
Tissues: Blood samples were collected following C02 asphyxiation and 
cardiac puncture and allowed to clot for 24 hours at 4°C. Serum was then 
separated from the clot by a three minute centrifugation in a microfuge, 
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collected, and stored at -20°C until the samples were used in either western 
immunoblot analysis or an enzyme linked immunosorbant assay (ELISA). 
Ceca were given a score indicating severity of the S. hyodysenteriae 
induced cecitis then were preserved in formalin. Within the scoring system, zero 
indicated no excess mucus or cecal atrophy, one indicated excess mucus with no 
cecal atrophy, two indicated excess mucus with partial cecal atrophy, three 
indicated excess mucus with total cecal atrophy, and four indicated excess mucus 
with total cecal atrophy and blood. 
The mesenteric lymph nodes and spleen were collected and minced 
through 60 mesh wire screens into RPMI 1640 Media (Sigma) containing 
10 mM HEPES buffer, 2 mM L-glutamine, penicillin/streptomycin (100 U/ml), 
gentamycin (0.05 mg/ml). The subsequent single cell suspensions were then 
immediately used in an ELISPOT assay. 
Western Immunoblot: A whole cell lysate of S. hyodysenteriae B204 
(100 µg) was denatured by boiling for two minutes with sodium dodecyl sulfate 
then electrophoresed on a 12.5% sodium dodecyl sulfate polyacrylamide gel 
using a Bio-rad Mini-Protean II Cell (165-2940) for 45 minutes. The resulting 
gel was then assemble into a Bio-rad Mini Trans-blot Electrophoretic Transfer 
Cell (170-3930) and blotted onto a nylon membrane (lmmobilon-P Transfer 
Membrane, Millipore) for one hour. The membrane was blocked with 5% skim 
milk in tris buffered saline (TBS) (29 g NaCl/L, 2.42 g Tris/L), pH 7.5, for one 
hour at 37°C. The membrane was then cut into strips and incubated for two 
hours with a mouse serum sample diluted 1:50 in TBS plus 0.2% skim milk. 
Alkaline phosphatase conjugated goat antibodies specific for mouse IgM, IgG, 
and IgA isotypes were then incubated with the membrane strips for one hour at 
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37°C at a 1:500 dilution in TBS plus 0.2% skim milk. Finally, the membrane 
strips were developed using Fast Red ( 4-chloro-2-methy lbenzenediazonium) ( 1. 5 
mg/ ml) and Naphthol-AS-MX phosphate (C19H 16N05PNai) (0.75 mg/ ml) 
suspended in tris buffer (2.5 g Tris-HCl/L) , pH 8.0 (36, 37) . 
ELISA Assay: Immulon-4 flat bottom plates (Dynatech Laboratories) 
were coated with a whole cell lysate of S. hyodysenteriae B204 (100 µg/ ml) in 
0.1 M PBS, pH 7 .2, overnight at 4°C. Serum samples from individual mice 
described above were diluted 1: 100 in normal saline solution plus 0.025 % Tween 
20 (TS) then incubated on the antigen coated plates for two hours at 37°C. After 
this incubation period, alkaline phosphatase conjugated goat antibody specific for 
mouse antibodies of either the IgM, IgG, or IgA isotype at a l: 2000 dilution in 
TS were incubated on the plate for one hour at 37°C so that each serum sample 
was tested for relative levels of the above mentioned isotypes. Lastly, p-
nitrophenyl phosphate disodium (Sigma, 104-0) (1 mg/ml) in a 0. 05 M sodium 
carbonate and l mM magnesium chloride solution, pH 9.3, was added to the 
plates as substrate. The plates were incubated for 75 to 90 minutes and read on a 
Microplate Autoreader EL 310 (Biotek Instruments) (57). 
ELISPOT Assay: Mesenteric lymph node and spleen single cell 
suspensions from the mice described above were put into 96-well plates with 
nitrocellulose backing (Millipore Multiscreen HV Filtration Plates). The wells 
had been previously coated with S. hyodysenteriae B204 ( 100 µg/ml) whole cell 
lysate, mouse anti-immunoglobulin (2 µg/ml) or whole cholera toxin (20 µg/ml) 
suspended in 0.1 M PBS, pH 7.2, 100 µ1 per well, and incubated at 4°C for 
eight hours. The cells were then incubated at 37°C and 7.5% C02 in the above 
described RPMI media also containing 5% fetal calf serum, 1:50 dilution of 
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P388D1 cell supernatant (source of murine IL-6), and Escherichia coli K235 
lipopolysaccharide (1 µg/ml) for 21 hours. The plates were washed and a mouse 
specific alkaline phosphatase conjugated secondary goat antibody diluted I :500 in 
TBS containing 0.05% Tween 20, pH 7.5, was incubated on the plates for 18 
hours at 4°C. Lastly, the plates were developed, as described above for western 
immunoblot, by the addition of Fast Red (1.5 mg/ml) and Naphthol (0. 75mg/ml) 
suspended in tris buffer as a substrate. The subsequent spots (Figure 1.) were 
counted using a dissecting microscope (4, 5). Each single cell suspension was 
tested for numbers of IgM, IgG, and IgA producing celJs. 
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FIGURE 1. The above photograph shows ELISPOT' s in one well of a ninety-six 
well nitrocellulose-backed culture plate. Each spot in the wel1 represents one 
antibody secreting cell (ASC) specific for the antigen with which the well was 
coated. 
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RESULTS 
Spleen cells, MLN cells, and serum were assayed for antibody 
production. This was done to ascertain if previous per os (P.O.) immunization 
with S. hyodysenteriae 8204 cellular antigens, employing cholera toxin as an 
adjuvant, resulted in a subsequent increase in antibody production over control 
mice or mice intraperioneally (I. P.) immunized. Mesenteric lymph node and 
spleen cells were assayed from i) naive control, ii) infected only, iii) 
intraperitoneally (l.P.) immunized and infected, and iv) P.O. immunized and 
infected mice in duplicate trials (Experiment One) using the ELISPOT technique. 
Samples were analysed at day ten or 17 post infection. Table 1 shows the number 
of specific ASC for S. hyodysenteriae 8204 antigens per million cells from either 
MLN or spleen at ten days post infection. An increase in specific ASC over naive 
control mice can be seen in all other groups for both IgG and IgA. The greatest 
increase in specific ASC over control was observed in the orally immunized and 
infected group. Similar results were also seen at day 17 (see Table 2). Specific 
serum antibody levels against S. hyodysenteriae 8204 antigens were also assayed 
by ELISA. At ten days post infection, only the previously immunized mice 
showed increased levels of specific serum IgG over control. Also at this ti me 
point, only the P.O. immunized plus infected mice showed an increased level of 
specifec serum lgA. At 17 days post infection, elevated levels of specific serum 
lgA had expanded to include all infected animals with the P.O. immunized group 
having the highest level (see Table 3). 
Cholera toxin was used as an oral adjuvant in conjunction with 
TABLE 1. Antibody Secreting Cells Specific for Serpulina hyodysenteriae, Ten Days Post Infectiona 
IgG 
IgA 
MLW 
Spleen 
MLN 
Spleen 
Naiveb 
0 
2±1 
2±0.9 
0 
Infectedc 
23 ± 5.6 
33±19 
125 ± 63.4 
137 ± 22.3 
I. P. Immunized 
and Infectedd 
18 ± 9.3 
348 ± 81.1 
27±16 
92± 63 
P.O. Immunized 
and Infectede 
335 ± 50.4 
1227 ± 335.6 
826 ± 15.2 
1767 ± 94.93 
a The values in this table are representative of two duplicate experiments and are expressed as S. hyodysenteriae 
B204 specific antibody secreting cells per million cells harvested from C3H/HeOuJ mice plus or minus the 
standard error of the mean (S.E.M.). These values are obtained from samples collected ten days post 
infection with 1 x 108 5. hyodysenteriae B204 and were determined using the ELISPOT technique. n=4. 
b The animals in the "Naive" group were neither immunized nor infected. 
c The animals in the "Infected" group were not immunized, but were infected. 
d The animals in the "LP. Immunized and Infected" group were injected twice intraperitoneally with 300 µg of 
a S. hyodysenteriae B2C4 cell lystate (days one and 13). The mice were infected 12 days after the last 
injection (day 25). 
e The animals in the "P.O. Immunized and Infected" group were immunized in the following manner. On days 
one, two, and three mice were intubated with a total of 500 µg of a S. hyodysenteriae B204 cell lysate, 30 µg 
of the cholera toxin B subunit, and 1.5 µg of whole cholera toxin; this immunization was repeated on days 13, 
14, and 15. The mice were infected ten days after the last intubation (day 25). 
f MLN = mesenteric lymph node. 
TABLE 2. Antibody Secreting Cells Specific for Serpulina hyodysenteriae, Seventeen Days Post lnfectiona 
IgG 
IgA 
MLW 
Spleen 
MLN 
Spleen 
Naiveb 
1±0.5 
6 .± 5 
1 .± 0.4 
1 .± 0.6 
Infectedc 
13 ± 5.4 
25 .± 8.1 
34 ± 4.5 
152 ± 6.46 
I. P. Immunized 
and lnfectedd 
6± 2 
237 ± 55 .7 
40± 11 
269 .± 76.4 
P.O. Immunized 
and lnfectede 
166 .± 68 
166 ± 31.9 
198 ± 36.8 
749 .± 59.9 
a The values in this table are representative of two duplicate experiments and are expressed as S. hyodysenteriae 
B204 specific antibody secreting cells per million cells harvested from C3H/HeOuJ mice plus or minus the 
standard error of the mean (S.E.M. ). These values are obtained from samples collected 17 days post 
infection with l x 1Q8 5. hyodysenteriae B204 and were determined using the ELISPOT technique. n=4. 
b The animals in the "Naive" group were neither immunized nor infected. 
c The animals in the "Infected" group were not immunized, but were infected. 
d The animals in the "LP. Immunized and infected" group were twice intraperitoneally injected with 300 µg of 
a S. hyodysenteriae B2C4 cell lysate (days one and 13). The mice were infected 12 days after the last 
injection (day 25). 
e The animals in the "P.O. Immunized and Infected" group were immunized in the following manner. On days 
one, two, and three, mice were intubated with a total of 500 µg of a S. hyodysenteriae B204 cell lysate, 30 µg 
of the cholera toxin B subunit, and 1.5 µg of whole cholera toxin; this immunization was repeated on days 13, 
14, and 15. The mice were then infected ten days after the last intubation (day 25). 
f MLN = mesenteric lymph node. 
TABLE 3. Specific Serum Antibody Level for Serpulina hyodysenteriaea 
IgG 
lg A 
10 Dayf 
17 Dayg 
10 Day 
17 Day 
Naiveb 
0.119 ± 0.008 
0.141 ± 0.002 
0. 022 ± 0. 003 
0. 090 ± 0. 007 
Infectedc 
0.134 ± 0.002 
0.241 ± 0.014 
0.062 ± 0.012 
0.232 ± 0.031 
I.P. Immunized 
and Infectedd 
0.543 ± 0.031 
0.468 ± 0.015 
0.027 ± 0.001 
0.157 ± 0.028 
P.O. Immunized 
and Infectede 
0.454 ± 0.016 
0.412 ± 0.017 
0.322 ± 0.046 
0.632 + 0.013 
a The values in this table are representative of two duplicate experiments and reflect the level of serum antibody 
specific for S. hyodysenteriae B204 collected from C3H/HeOuJ mice at ten or 17 days post infection 
with 1 x 108 S. hyodysenteriae B204 organisms. The values were measured via the ELISA technique and 
subsequent absorbance was recorded at 405 nm. Each absorbance value is given plus or minus its standard 
error of the mean (S.E.M.). Serum was diluted 1: 100. Duplicate wells were done for each sample. n=4. 
b The animals in the "Naive" group were neither immunized nor infected. 
c The animals in the "Infected" group were not immunized, but were infected. 
d The animals in the "I.P. Immunized and Infected" group were twice intraperitoneally injected with 300 µg of 
a S. hyodysenteriae B2C4 cell lysate (days one and 13). The mice were infected 12 days after the last 
injection (day 25). 
e The animals in the "P.O. Immunized and Infected" group were twice immunized in the following manner. On 
days one, two, and three, mice were intubated with a total of 500 µg of a S. hyodysenteriae B204 cell lysate, 
30 µg of the cholera toxin B subunit, and 1. 5 µg of whole cholera toxin; this immunization was repeated on 
days 13, 14, and 15. The mice were infected ten days after the last intubation (day 25). 
f Day 10 = ten days post infection. 
g Day 17 = 17 days post infection. 
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S. hyodysenteriae 8204 cellular lysate to determine if its use enhanced antibody 
production in mice. Mesenteric lymph node and spleen cells were assayed in 
duplicate trials (Experiment Three) using the ELISPOT technique from the 
following four groups: i) naive control mice, ii) infected control mice, iii) P.O. 
immunized (lmg cellular antigens) without cholera toxin (C.T.) and infected, 
and iv) P.O immunized (500 µg cellular antigens) with C.T. and infected. 
Tables 4 and 5 show the specific ASC at 17 days post infection for S. 
hyodysenteriae B204 per million cells of the MLN or spleen, respectively. In 
trial one, immunization with cholera toxin enhanced specific antibody production 
in comparison to all other groups (Table 4). In trial two, cholera toxin only 
enhanced the specific systemic IgA response (Table 5). Table 6 shows the 
specific serum antibody levels against S. hyodysenteriae B204 in both 
experiments by using the ELISA technique. An increase in specific serum 
antibody IgG and lgA isotypes was observed in all groups of mice relative to 
naive controls and the greatest increase was demonstrated in mice orally 
immunized with cholera toxin and spirochetal antigen. 
Spleen, MLN, and serum were assayed for antibody responses specific 
for S. hyodysenteriae B204 over a period of 30 days. This was done to 
determine if the enhanced antibody production seen at ten and 17 days 
represented an enhanced antibody response over infected only mice or just a 
faster one (Experiment Three). Mesenteric lymph node and spleen cells from 
naive control mice, infected control mice, and P.O. immunized and infected 
mice were assayed for specific ASC against S. hyodysenteriae B204. Figures 2 
and 3 show the resulting specific lgA ASC for the MLN and spleen, 
respectively, in the infected control and orally immunized groups. The results 
TABLE 4. Antibody Secreting Cells from Mesenteric Lymph Node Specific for Serpulina hyodysenteria& 
Naiveb Infectedc 
IgG Trial One 4±3 22±30 
Trial Two 1±1 2± 1 
IgA Trial One 7±3 120 ± 7.79 
Trial Two 2± 1 26 ± 3.7 
P.O. Immunized 
and Infected 
No C.T.d 
52± 18 
23± 9.2 
125 ± 8.5 
205 ± 67.1 
P.O. Immunized 
and Infected 
With C.T.e 
328 ± 7.32 
7±4 
524 ± 92.2 
92 ± 19.2 
a The values in this table are from two duplicate trials and are expressed as S. hyodysenteriae B204 specific 
mesenteric lymph node antibody secreting cells per million cells harvested from C3H/HeOuJ mice plus or 
minus the standard error of the mean (S.E.M.). These values are obtained from samples collected 17 
days post infection with 1 x 1Q8 S. hyodysenteriae B204 as determined using the ELISPOT technique. n=3. 
b The animals in the "Naive" group were neither immunized nor infected. 
c The animals in the "Infected" group were not immunized, but were infected. 
d The animals in the "P.O. Immunized and Infected No C.T." group were immunized in the following 
manner. On days one, two, and three, mice were intubated with a total of 1 mg of a S. hyodysenteriae B204 
cell lysate; this immunization was repeated on days 13, 14, and 15. The mice were infected ten days 
after the last intubation (day 25). 
e The animals in the "P.O. Immunized and Infected With C.T." group were immunized in the following 
manner. On days one, two, and three mice were intubated with a total of 500 µg of a S. hyodysenteriae B204 
cell lysate, 30 µg of the cholera toxin B subunit, and 1.5 µg of whole cholera toxin; this immunization was 
repeated on days 13, 14, and 15. The mice were infected ten days after the last intubation (day 25). 
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TABLE 5. Antibody Secreting Cells from Spleen Specific for Serpulina hyodysenteria& 
Naiveb 
IgG Trial One 1± 1 
Trial Two 0 
IgA Trial One 6±5 
Trial Two 0 
Infectedc 
11 ± 3.6 
I± 1 
301± 86.3 
84±20 
P.O. Immunized 
and Infected 
No C.T.<l 
27 ± 1.6 
11 ± 3.7 
291 ± 37.7 
213 + 32.1 
P.O. Immunized 
and Infected 
With C.T.8 
151 ± 32 
37 ± 22 
1031 ± 99.78 
593 ± 106 
a The values in this table are from two duplicate trials and are expressed as S. hyodysneteriae B204 specific 
spleen antibody secreting cells per million cells harvested from C3H/HeOuJ mice plus or minus the standard 
error of the mean (S.E.M.). These values are obtained from samples collected 17 days post infection 
with 1 x 108 S. hyodysenteriae B204 as determined using the ELISPOT technique. n=3. 
b The animals in the "Naive" group were neither immunized nor infected. 
c The animals in the "Infected" group were not immunized, but were infected. 
d The animals in the "P.O. Immunized and Infected No C.T." group were immunized in the following 
manner. On days one, two, and three mice were intubated with a total of 1 mg of a S. hyodysenteriae B204 
cell lysate; this immunization was repeated on days 13, 14, and 15. The mice were infected ten days 
after the last intubation (day 25). 
e The animals in the "P.O. Immunized and Infected With C. T." group were immunized in the following 
manner. On days one, two, and three, mice were intubated with a total of 500 µg of a S. hyodysenteriae 
B204 cell lysate, 30 µg of the cholera toxin B subunit, and 1.5 µg of whole cholera toxin; this immunization 
was repeated on days 13, 14, and 15. The mice were infected ten days after the last intubation (day 25). 
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TABLE 6. Serum Antibody Level Specific for Serpulina hyodysenteria& 
Naiveb 
IgG Trial One 0.120 ± 0.027 
Trial Two 0.171_± 0.110 
IgA Trial One 0.105 ± 0.031 
Trial Two 0. 060 ± 0. 004 
Infectedc 
0.218 ± 0.037 
0.283 ± 0.018 
0.169 ± 0.012 
0.137 ± 0.004 
P.O. Immunized 
and Infected 
No C.T.d 
0.326 ± 0.007 
0.409 ± 0.020 
0.206 ± 0.021 
0. 200 ± 0. 025 
P.O. Immunized 
and Infected 
With C.T. e 
0.946 ± 0.064 
0. 343 ± 0. 020 
1.356 ± 0.140 
0.306 ± 0.017 
a The values in this table are from two duplicate trials and reflect the level of serum antibody specific for S. 
hyodysenteriae B204 collected from C3H/HeOuJ mice at 17 days post infection with 1 x 1Q8 S. 
hyodysenteriae B204. The values were determined via the ELISA technique and the subsequent light 
absorbance was recorded at 405 nm. Each absorbance value is given plus or minus its standard error of the 
mean (S.E.M.). Serum was diluted 1: 100. Duplicate wells were done for each sample. n=3. 
b The animals in the "Naive" group were neither immunized nor infected. 
c The animals in the "Infected" group were not immunized, but were infected. 
d The animals in the "P.O. Immunized and Infected No C. T." group were immunized in the following 
manner. On days one, two, and three, mice were intubated with a total of 1 mg of a S. hyodysenteriae B204 
cell lysate; this immunization was repeated on days 13, 14, and 15. The mice were then infected ten days 
after the last intubation (day 25). 
e The animals in the 11 P. 0. Immunized and Infected With C. T. 11 group were immunized in the following 
manner. On days one, two, and three mice were intubated with a total of 500 µg of a S. hyodysenteriae B204 
cell lysate, 30 µg of the cholera toxin B subunit, and 1.5 µg of whole cholera toxin; this immunization was 
repeated on days 13, 14, and 15. The mice were infected ten days after the last intubation (day 25). 
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FIGURE 2. Detection of lgA antibody secreting cells (ASC) which are specific 
for a whole cell lysate of Serpulina hyodyaenteriae 8204. Results are depicted 
as the average of ASC per million mesenteric lymph node cells . These results 
were determined by ELISPOT at four time points post infection with I x I os 
organisms of S. hyodysenteriae B204. The solid bars represent control infected 
mice. The hatched bars represent mice immunized in the following manner. On 
days one, two, and three, mice were oraJly intubated with a total of 500 µg of 
S. hyodysenteriae B204 cell lysate, 30 µg of the cholera toxin B subunit, and 1.5 
µg of whole cholera toxin in a total volume of 0.3 ml; this immunization was 
repeated on days 13, 14, and 15. The mice were infected ten days after the last 
intubation (day 25). 
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FIGURE 3. Detection of IgA antibody secreting cells (ASC) which are specific 
for a whole cell lysate of Serpulina hyodysenteriae B204. Results are depicted as 
the average of ASC per million spleen cells. These results were determined by 
ELISPOT at four time points post infection with l x 108 organisms of S. 
hyodysenteriae B204. The solid bars represent control infected mice. The 
hatched bars represent mice immunized in the following manner. On days one, 
two, and three mice were orally intubated with a total of 500 µg of S. 
hyodysenteriae B204 cell 1ysate, 30 µg of the cholera toxin B subunit, and 1.5 µg 
of whole cholera toxin in a total volume of 0.3 ml; this immunization was 
repeated on days 13, 14, and 15. The mice were infected ten days after the last 
intubation (day 25). 
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of specific lgG ASC mirror the lgA results (data not shown). Orally immunized 
mice show the highest ASC numbers at ten days post infection while infected 
control mice show highest ASC numbers at 30 days post infection. Specific 
serum antibody levels against S. hyodysenteriae B204 were also assayed. Figures 
4 and 5 show these results for lgA and IgG, respectively , in the infected control 
and orally immunized groups. In genera] , antibody levels continued to rise in 
both groups over the experimental period. Naive mice continued to have 
negative ELISA responses to S. hyodysenteriae B204 antigens over the entire 
assaying period. 
The western immunoblot technique was also used to analyze collected 
serum for specificity againt whole cell antigens of S. hyodysenteriae B204. 
Western blot reactivity was subsequently observed for previously immunized 
mice or mice that had been infected with S. hyodysenteriae for at least ten days. 
However, no unique antigen bands were identified that related to protection from 
disease (Figure 6). 
Ceca from mice were scored for severity of S. hyodysenteriae induced 
cecitis. No consistent difference in disease was found between the immunized 
and control mouse groups following challenge (Table 7). 
A 
B 
s 
0 
R 
B 
A 
N 
c 
E 
A 
T 
4 
0 
5 
N 
M 
53 
0.9 
0.8 
0.7 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0.0 
-0.1 
3 10 17 30 
DAYS POST INFECTION 
FIGURE 4. Measurement of Serpulina hyodysenteriae 8204 specific IgA serum 
antibody responses at various times post challenge. Antibody levels were 
measured by ELISA (405 nm) at four time points post infection with 1 x 108 S. 
hyodysenteriae B204. The solid bars represent the response of mice which had 
been infected, but not vaccinated. The hatched bars represent mice immunized 
in the following manner. On days one, two, and three mice were orally 
intubated with a total of 500 µg of S. hyodysenteriae 8204 cell lysate, 30 µg of 
the cholera toxin B subunit, and 1.5 µg of whole cholera toxin in a total volume 
of 0.3 ml; this immunization was repeated on days 13, 14, and 15. The mice 
immunized were infected ten days after the last intubation (day 25). 
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FIGURE 5. Measurement of S. hyodysenteriae B204 specific IgG serum 
antibody responses at various times post challenge. Antibody levels were 
measured by ELISA ( 405 nm) at four time points post infection with 1 x 108 S. 
hyodysenteriae B204. The solid bars represent the response of mice which had 
been infected, but not vaccinated. The hatched bars represent mice immunized 
in the following manner. On days one, two, and three, mice were orally 
intubated with a total of 500 µg of a S. hyodysenteriae B204 cell lysate, 30 µg of 
the cholera toxin B subunit, and 1.5 µg of whole cholera toxin in a total volume 
of 0.3 ml; this immunization was repeated on days 13, 14, and 15. The 
immunized mice were infected ten days after the last intubation (day 25). 
FIGURE 6. Photograph of a western immunoblot. The antigen was a Serpulina 
hyodysenteriae B204 cellular lysate separated on a 12.5% sodium dodecyl 
sulfate-polyacrylamide gel. Lanes are numbered from left to right. Lane one 
shows bands recognized by a positive control serum (a mouse hyperimmunized 
intraperitoneally with S. hyodysenteriae B204 cellular lysate). Lanes two 
through five were developed with serum from naive control mice. Lanes six 
through nine were developed from mice treated in the following manner. On 
days one, two, and three mice were orally intubated with a total of 500 µg of a 
S. hyodysenteriae B204 cellular lysate, 30 µg of cholera toxin subunit B, and 1.5 
µg whole cholera toxin; this immunization was repeated on days 13, 14, and 15. 
Mice were infected with l x 10s S. hyodysenteriae B204 on day 25. Lastly, 
these mice were sacrificed 17 days post infection. Lane 10 shows molecular 
weight standards. Bands represent cellular lysate molecules of S. hyodysenteriae 
B204 for which mice have formed specific antibodies. 
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TABLE 7. Average Cecal Scores2 of Serpulina hyodysenteriae Infected Mice 
Day 10& 
Day 17i 
Naiveb Infectedc I. P. Immunizedd 
and Infected 
0.21 ± 0.14 2.07 ± 0.36 2.21 ± 0.22 
0. 14 ± 0.09 2.36 ± 0.22 2.00 ± 0.34 
P.O. Immunizecie 
and Infected 
NoC.T. 
2.58 ± 0.45 
P.O. Immunizedf 
and Infected 
With C.T. 
2.50 ± 0.23 
2.32 ± 0.19 
a Severity of S. hyodysenteriae B204 induced cecitis in mice were rated in the following manner. The score 
zero represents no excess mucus or cecal atrophy, one represents excess mucus, but no cecal atrophy, two 
represents excess mucus with complete cecal atrophy and blood. Mice were infected with 1 x 1Q8 S. 
hyodysenteriae B204. 
b The animals in the "Naive"group were neither immunized nor infected.n=7 (ten days post infection). n=14 
(17 day post infection). 
c The animals in the "Infected" group were not immunized, but were infected. n=7 (ten days post infection). 
n= 14 (17 days post infection). 
d The animals in the "I.P. Immunized and Infected" group were injected twice intraperitoneally with 300 µg of 
a S. hyodysenteriae B204 cell lysate (days one and 13). The mice were infected 12 days after the last 
injection (day 25). n=7 (ten days post infection) n=8 (17 days post infection). 
e The animals in the "P.O. Immunized and Infected No C. T." group were immunized in the following manner. 
On days one, two, and three, mice were intubated with a total of 1 mg of a S. hyodysentenae B204 cell 
lysate; this immunization was repeated on days 13, 14, and 15. The mice were infected ten days after the last 
intubation (day 25). n= 6. 
f The animals in the "P.O. Immunized and Infected With C.T." group were immunized in the following 
manner. On days one, two, and three, mice were intubated with a total of 500 µg of a S. hyodysenteriae 
B204 cell lysate, 30 µg of the cholera toxin B subunit, and 1. 5 µg o whole cholera toxin; this immunization 
was repeated on days 13, 14, and 15. The mice were infected ten days after the last intubation (day25). 
n=7 (ten days post infection) n=l4 (17 days post infection). 
g These mice were sacrificed ten days post infection. 
h ND = not determined. 
i These mice were sacrificed 17 days post infection. 
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DISCUSSION 
Swine dysentery has been difficult to control by immunization. Neither 
the parenteral route nor the oral route have been successful (8, 15, 16). 
Serpulina hyodysenteriae does not invade past the lamina propria ( 1, 23, 52) 
Therefore, it is likely that parenteral immunization may not adequately prime the 
mucosa! immune system for a protective response against S. hyodysenteriae. In 
addition, the oral route may be an inefficient method of presenting S. 
hyodysenteriae antigens. Previously, it has been shown that cholera toxin (C. T.) 
can enhance the immune response at mucosa! surfaces to substances that are poor 
immunogens such as ovalbumin and some streptococcal antigens (6, 14). In 
addition, protection to Sendai virus infection has been demonstrated when C. T. 
was used as an adjuvant. Protection was directly related to specific IgA titres at 
the mucosa! surface (28). In the present study , the effect of C. T . on the murine 
B lymphocyte response to S. hyodysenteriae antigens presented orally was 
explored. 
Cholera toxin given orally with a whole cell Jysate of S. hyodysenteriae 
six times before infection was shown to prime for enhanced antibody production 
both in the spleen and MLN. This was more effecacious than LP. immunization 
or infection (Tables l & 2). The antibody production was determined by 
assaying specific antibody secreting cell (ASC) numbers against S. 
hyodysenteriae at ten and 17 days post infection. However, infected control 
mice and I. P. immunized mice were not unresponsive to immunization and/or 
infection. These two groups did develop increased specific IgG and IgA ASC as 
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compared to naive mice. Because of the proximity of the MLN to the gut it is 
probable that the immune response in this tissue reflects an equally vigorous or 
even greater response in the intestinal lamina propria (3, 32). However, this 
response did not result in immune protection or resolution of lesions (Table 7). 
Assaying for specific serum antibody levels at ten days post infection indicated 
that the LP. immunization mainly primed the systemic immune system while oral 
immunization primed both the systemic and mucosa} immune response (Table 3). 
This would be consistent with the results obtained by other investigators (33). 
The ability of oral immunization to augment mucosa! immunity to S. 
hyodysenteriae B204 was examined. Mice were immunized P.O. with a whole 
cell lysate of S. hyodysenteriae 8204 in combination with or without C. T. The 
ASC response in MLN and spleen, as well as serum antibody, was evaluated. In 
the spleen, oral immunization with C. T. enhanced antibody production over oral 
immunization without C. T. in duplicat trials. This was demonstrated by elevated 
numbers of S. hyodysenteriae specific ASC 17 days post infection. This was 
most pronounced for specific IgA ASC (Table 5). However, measurement of 
specific ASC in the MLN did not give similar results in the duplicat trials. One 
trial showed an increased number of specific ASC in the mice orally immunized 
with C.T. while the other did not (Table 4). The differences seen may reflect 
the variability of the specific ASC numbers with time (Figures 2 & 3). 
Additionally, the increased number of specific IgG and lgA ASC in the MLN of 
mice orally immunized with C. T. in one trial was accompanied by a high level 
of specific lgG and lgA antibody in the serum. In the other trial, lower numbers 
of S. hyodysenteriae specific ASC in the MLN were also reflected by a lower 
specific serum antibody level (Table 6). This indicates that the serum antibody 
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detected in orally intubated animals may in large part come from stimulated 
mucosa! sites and not systemic sites. Serpulina hyodysenteiae specific serum 
antibody was present in all the infected groups. These results indicate that while 
cholera toxin can augment the induction of an immune response to S. 
hyodysenteriae antigens at the gut surface, the antigens themselves are also 
significantly immunogenic (Tables 4 & 5). 
Mice infected with S. hyodysenteriae were assayed for specific serum 
antibody levels and specific ASC responses against S. hyodysenteriae antigens at 
various times post infection for 30 days. Specific ASC in orally immunized and 
infected mice peaked at ten days post infection while the ASC responses of 
infected control mice were maximal on day 30 (Figures 2 & 3). Both specific 
lgG and IgA serum antibody levels continued to rise over the experimental 
period (Figures 4 & 5). These results indicate oral intubation primed the 
immune system for a strong secondary immune response to S. hyodysenteriae 
antigens. It has not been conclusively proven, however, to enhance the level of 
the antibody secreted from the intestinal site during the course of the disease. 
The different peak times for specific ASC numbers seen in the MLN and spleen 
between orally immunized and infected control mice may simply be a measure of 
the B lymphocyte trafficking to the lamina propria. The actual numbers of 
specific ASC become similar over time as evidenced by the specific lgG serum 
response and to a lesser extent the specific IgA serum response (Figures 4 & 5). 
Serpulina hyodysenteriae B204 specific IgM ASC in the spleen and 
MLN and specific lgM serum antibody was also assayed in the above 
experiments (data not shown). Specific IgM ASC were seen early in the spleen 
after challenge and was followed by specific IgM in the serum. Whole cholera 
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toxin specific IgM ASC were also observed in the spleen after challenge, but 
were at lower numbers compared to S. hyodysenteriae specific ASC (data not 
shown). 
A general increase in nonspecific ASC was also observed (data not 
shown) , particularily with IgA. These nonspecific ASC may recognize antigens 
of normal microflora. If this is the case, the role of secondary bacteria in the 
development of swine dysentery, as demonstrated with gnotobiotic animals, 
would be further supported (11, 12, 21 , 37, 55). 
Regardless of the immunization protocol, no predictor of protection 
against S. hyodysenteriae induced cecitis in the mouse model for swine dysentery 
could be found. This may indicate that antibody mediated immunity will be 
unprotective against S. hyodysenteriae even though lgA levels become elevated. 
This may be because the antigenic sites on the bacteria do not affect 
neutralization and/or opsonization. Alternately, the damaged epithelium may not 
effectively express and attach secretory component to dimeric IgA. This could 
make the antibody multimer more susceptible to degradation. If the intial lesion 
begins with affected epithelial cells, a large amount of intact, dimeric lgA bound 
to secretory component might effectively prevent swine dysentery. The presence 
of Lactogenic immunity and partial immunity from recent exposure to S. 
hyodysenteriae supports this hypothesis (12). 
In the mouse model, flagellar antigen from S. hyodysenteriae may confer 
immunity (2, 7) and S. hyodysenteriae LPS has also been implicated in immunity 
to swine dysentery ( 12, 22, 42, 43). Therefore, it is possible that C. T. in 
combination with the appropriate immunogens may affect a protective immune 
response. However, it must be noted that western blot analysis of specific serum 
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antibody against S. hyodysenteriae 8204 LPS and flagella were detected in the 
present studies; ther fore, the presence of these specific antibodies do not support 
the protective role of serum antibody specific for flagella or LPS (Figure 6). 
In conclusion, a whole cell lysate of S. hyodysenteriae B204 orally 
intubated with C. T. primed the systemic and mucosa.I immune systems for a 
stronger secondary antibody response over LP. immunization. Oral 
immunization without C. T. did not induce a systemic IgA response as well as 
oral immunization with C. T., but it may have primed the mucosa! immune 
system equally well. No correlation between increased ASC in the MLN or 
spleen of mice could be found with protection against S. hyodysenteriae induced 
cecitis nor could serum antibody specificty or level be correlated to protection. 
64 
REFERENCES CITED 
1. Albassam, M.A., H.J. Olander, H. L. Thacker, and J. J. Turek. 
1985. Ultrastructural characterization of colonic lesions in pigs 
inoculated with Treponema hyodysenteriae. Can. J. Comp. Med. 
49:384-390. 
2. Boyden, D. A., F. G. Albert, and C. S. Robinson. 1989. Cloning and 
characterization of Treponema hyodysenteriae antigens and protection 
in a CF-1 mouse model by immunization with a cloned endoflagellar 
antigen. Infect lmmun. 57:3808-3815. 
3. Clarke, C. J., A. D. Wilson, N. A. Williams, and C.R. Stokes. 
1991. Mucosa! priming of T lymphocyte responses to fed protein 
antigens using cholera toxin as an adjuvant. 72:323-328. 
4. Current Protocols in Immunology, Volume One... 1991. New York: 
Green Publishing Associates and Wiley-lnterscience. Unit 7.14: 
pp. 7.14. l - 7 .14.6. 
5. Czerkinsky, C. C., L. Nilsson, H. Nygren, 0. Ouchterlony, and A. 
Tarkowski. 1983. A solid-phase enzyme-linked immunospot 
(ELISPOT) assay for enumeration of specific antibody-secreting cells. 
J . Immunol. Meth. 65: 109- 121 . 
6. Czerkinsky, C., M. W. Russell, N. Lycke, M. Lindblad, and J. 
Holmgren. 1989. Oral administration of a streptococcal antigen coupled 
to cholera toxin B subunit evokes strong antibody responses in salivary 
glands and extramucosal tissues. Infect. Immun. 57: 1072-1077. 
65 
7. Gabe, J. D., M. McCaman, M. J. Kennedy, E. L. Rosey, and R. J. 
Yancey. 1993. Cloning and DNA sequence analysis of OsBl, a 
Serpulina hyodysenteriae gene encoding a periplasmic flagellar core 
protein. P7 In: 74th Ann. Mtg. Conf. Res. Workers in Animal Disease, 
Chicago, IL. 
8. Glock, R. D., K. J. Schwartz, and D. L. Harris. 1978. Parenteral 
immunization of pigs against infection with Treponema hyodysenteriae. 
Am. J. Yet. Res. 39:639-642. 
9. Greer, J.M. and M. J. Wannemuebler. 1989. Pathogenesis of 
Treponsema hyodysenteriae: Induction of interleukin-I and tumor 
necrosis factor by a treponemal butanol I water extract (endotoxin). 
Microb. Pathogen. 7:279-288. 
10. Harris, D. L., R. D. Glock, C.R. Christenson, and J.M. Kinyon. 
1972. Swine dysentery-I. Inoculation of pigs with Treponema 
hyodysenteriae (new species) and reproduction of the disease. Yet. 
Med. Small Animal Clin. 67:61-64. 
11. Harris , D. L., T. J. L. Alexander, S. C. Whipp, I. M. Robinson, R. 
D. Glock, and P. J. Matthews. 1978. Swine dysentery: Studies of 
gnotobiotic pigs inoculated with Treponema hyodysenteriae, Bacteroides 
vulgatus, Fusobacterium necrophorum. J. Am. Vet. Med. Assoc. 
172:468-471. 
12. Harris, D. L. and R. J. Lysons. 1992. Diseases Qf Swine, 1th Edition. 
Ames: Iowa State University Press. Chapter 49: pp.599-616. 
13. Hayashi, T., I. Suenaga, T. Komeda, and T. Yamazaki. 1990. Role 
66 
of Bacteroides uniformis in susceptibility of Ta:CF#l mice to infection 
by Treponema hyodysenteriae. Zbl. Bakt. 274: 118-125. 
14. Heijden, P. J. van der, A. T. J. Bianchi, M. Doi, J. W. Pals, W. 
Stok, and B. A. Bokhout. 1991. Manipulation of intestinal immune 
response against ovalbumin by cholera toxin and its B subunit in mice. 
lmmunol. 72:89-93. 
15. Hudson, M. J. , T. J. L. Alexander, and R. J. Lysons. 1974. Swine 
dysentery: Failure of an attenuated strain of spirochete, given orally, 
to protect pigs against subsequent challenge. Br. Vet. J. 130:37-41. 
16. Hudson, M. J. , T. J. L. Alexander, and R. J. Lysons. 1976. Swine 
dysentery: Protection of pigs by attenuated Treponema hyodysenteriae. 
Res. Vet. Sci. 21:366-367. 
17. Hughes, R. , H.J. Olander, and C. B. Williams. 1975. Swine 
dysentery: Pathogenicity of Treponema hyodysenteriae. Am. J. Vet. 
Res. 36:971-977. 
18. Joens, L.A. and R. D. Glock. 1979. Experimental infection in mice 
with Treponema hyodysenteriae. Infect. lmmun. 22: 132-135. 
19. Joens, L.A., D. L. Harris, and D. H. Baum. 1979. Immunity to 
swine dysentery in recovered pigs. Am.J. Vet. Res. 40: 1352-1354. 
20. Joens, L. A. , R. D. Glock, S. C. Whipp, I. M. Robinson, and D. L. 
Harris. 1981. Location of Treponema hyodysenteriae and synergistic 
anaerobic bacteria in colonic lesions of gnotobiotic pigs. Vet. Microbiol. 
6:69-77. 
21. Joens, L.A. , I. M. Robinson, R. D. Glock, and P. J . Matthews. 
67 
1981. Production of lesions in gnotobiotic mice by inoculation with 
Treponema hydysenteriae. Infect. lmmun. 31 :504-506. 
22. Joens, L. A. 1990. Historical Overview and Research Update .on Enteric 
Diseases of Swine. Manhattan, KS: Agricultural Experimental Station, 
Kansas State University. pp. 48-51 2 
23. Kennedy, M. J. , D. K. Rosnick, R. G. Ulrich, and R. J. Yancey. 
1988. Association of Treponema hyodysenteriae with porcine intestinal 
mucosa. J. Gen. Microbiol. 134: 1565-1567. 
24. Kent, K. A. and R. M. Lemcke. 1984. Purification and cytotoxic 
activity of a haemolysin produced by Treponema hyodysenteriae. 
p. 785, ln: Abstracts of the International Pig Veterinary Society, Ghent, 
Belgium. 
25. Kent, K. A., R. M. Lemcke, and R. J. Lysons. 1988. Production, 
purification and molecular weight determination of the haemolysin of 
Treponema hyodysenteriae. J. Med. Microbiol. 27:215-224. 
26. Knoop, F. C. 1981. Investigation of a hemolysin produced by 
enteropathogenic Trepeonema hyodysenteriae. Infect. Immun. 
31: 193-198. 
27. Lemcke, R. M. and M. R. Burrows. 1982. Studies on a haemolysin 
produced by Treponema hyodysenteriae. J. Med. Microbiol.15:205-214. 
28. Liang, X. , M. E. Lamm, and J. G. Nedrud. 1988. Oral 
administration of cholera toxin-Sendai virus conjugate potentiates gut 
and respiratory immunity against Sendai virus. J. lmmunol. 
141: 1495-1501. 
68 
29. Liang, X., M. E. Lamm, and J. G. Nedrud. 1989. Cholera toxin as a 
mucosa! adjuvant for respiratory antibody responses in mice. Reg. 
lmmunol. 2:244-248. 
30. Lowry, 0. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 
1951 . Protein measurement with the Polin phenol reagent. J. Biol. 
Chem. 193:265-275. 
31. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. 
Hirasawa, and H. Kiyooo. 1992. The mucosal immune system from 
fundamental concepts to vaccine development. Vaccine. 10:75-88. 
32. Merchant, A. A., W. S. Groene, E. H. Cheng, and R. D. Shaw. 
1991. Murine intestinal antibody response to heterologous rotavirus 
infection. J. Clin. Microbiol. 29:1693- 1701. 
33. Mestecky, J. and J. R. McGhee. 1987. Immunoglobulin A (IgA): 
Molecular and cellular interactions involved in IgA biosynthesis and 
immune response. Advances Immunol. 40: 153-228. 
34. Meyer, R. C., J. Simon, and C. S. Byerly. 1974. The etiology of 
swine dysentery I. Oral inoculation of germ-free swine with 
Treponema hyodysenteriae and Vibrio cob. Vet. Pathol. 11:515-526. 
35. Meyer, R. C., J. Simon, and C. S. Byerly. 1975. The etiology of 
swine dysentery III. The role of selected gram negative obligate 
anaerobes. Vet. Pathol. 12:46-54. 
36. Mini Il Dual S.la.b Instruction Manual. 1990. Richmond, CA: Bio-Rad 
Laboratories. 
37. Mini Trans-Blot Electrophoretic Transfer Cell lntstruction Manual. 
1990. Richmond, CA: Bio-Rad Laboratories. 
69 
38. Mysore, J. V., G. E. Duhamel, and M. R. Mathiesen. 1992. 
Morphologic analysis of enteric lesions in conventional and 
streptomycin-treated inbred C3H/HeN mice infected with Serpulina 
(Treponema) hyodysenteriae. Lab. Animal Sci. 42: 7- 12. 
39. Nibbelink, S. K., D. C. Morfitt, and M. J. Wannemuehler. 1990. 
Comparative effects of Treponema. hyodysenteriae and Treponema. 
innocens infection in germ free mice. p. 13 In: 71 st Ann. Mtg. Conf. 
Res. Workers in Animal Disease, Chicago, IL. 
40. Nibbelink, S. K. and M. J. Wannemuebler. 1991. Susceptibility of 
inbred mouse strains to infection with Serpula ( Treponema.) 
hydysenteriae. Infect. Immun. 59:3111 -3 118. 
41. Nibbelink, S. K. 1992. The role of tumor necrosis factor and 
secondary bacteria in the pathogenesis of swine dysentery. Ph.D. 
dissertation, Iowa State University. 
42. Nu~n, M. E., J . R. Birmingham, and L. A. Joens. 1982. 
Biological activity of a lipopolysaccharide extracted from Treponema 
hyodysenteriae. Infect. Immun. 37: 138-142. 
43. Nuessen, M. E., L. A. Joens, and R. D. Glock. 1983. Involvement of 
lipopolysaccharide in the pathogenicity of Treponema hyodysenteriae. J. 
Immunol. 131:997-999. 
44. Ogawa, T., M. L. McGhee, Z. Moldoveanu, S. Hamada, J. 
Mestecky, J. R. McGhee, and H. Kiyono. 1989. Bacteroides-specific 
IgG and IgA subclass antibody secreting cells isolated from chronically 
inflamed gingival tissues. Clin. Exp. Immunol. 76: 103-110. 
70 
45. Ogawa, T. , Y. Kono, M. L. McGhee, J.E. Roberts, S. Hamada, 
and H. Kiyono. 1991. Porphyromonas gingivalis-specific serum IgG 
and IgA antibodies originated from immunoglobulin secreting cells in 
inflamed gingiva. Clin. Exp. lmmunoJ. 83:237-244. 
46. Olson, L. D. 1974. Clinical and pathological observations on the 
experimental passage of swine dysentery. Can. J. Comp. Med. 
38:7- 13. 
47. Parizek, R., R. Stewart, K. Brown, and D. Blevins. 1985. Protection 
against swine dysentery with an inactivated Treponel1111 hyodysenteriae 
bacterin. Vet. Med. July 1985. 
48. Rees, A. S., R. J. Lysons, C.R. Stokes, and F. J. Bourne. 1989. 
Antibody production by the pig colon during infection with Treponel1111 
hyodysenteiae. Res. Vet. Sci. 47:263-269. 
49. Roth, J. A. 1992. Diseases .o.f Swine, 1th Edition. Ames: Iowa State 
University Press. Chapter 3: pp. 21 -39. 
50. Saheb, S. A. and L. Lafleur. 1980. Characteristics of the interaction of 
a treponemal hemolysin with rabbit erythrocytes. Biochimie. 
62:787-793. 
51. Saheb, S. A., R. Lallier, L. Massicotte, L. Lafleur, and S. Lemieux. 
1981 . Biological activity of Treponel1111 hyodysenteriae hemolysin. 
Current Microbiol. 5:91 -94. 
52. Stanton, T. B. and D. F. Lebo. 1988. Treponema hyodysenteriae 
growth under various culture conditions. Vet. Microbiol. 18: 177-190. 
71 
53. Suenaga, I. and T. Yamazaki. 1983. Experimental infecton with 
Treponema hyodysenteriae in nude mice. Zbl. Ba.kt. Hyg. I Abt. Orig. 
A 254:528-533. 
54. Taylor, D. J. and T. J. Alexander. 1971. The production of dysentery 
in swine by feeding cultures containing a spirochaete. Br. Yet. J. 
127:1vii- l xi 
55. Teige, J., T. Landsverk, A. Lund, and H.J. Larsen. 1981. Swine 
dysentery: A scanning electron microscopy investigation. Acta. Yet. 
Scand. 22:218-225. 
56. Tomasi, Thomas B. 1989. Regulation of the mucosa! IgA response -
an overview. Immunol. Invest. 18: 1- 15. 
57. Voller, A., D. E. Bidwell, and A. Bartlett. 1977. Ih.e Enzyme Linked 
Immunosorbant Assa}'. (ELISA). Guernsey, Europe: Flow line 
Publications. pp. 3-25. 
58. Wannemuehler, M. J., R. D. Hubbard, and J.M. Greer. 1988. 
Characterization of the major outer membrane antigens of Treponema 
hyodysenteriae. 56: 3032-3039. 
59. Whipp, S. C., I. M. Robinson, D. L. Harris, R. D. Glock, P. J. 
Matthews, and J. L. Alexander. 1979. Pathogenic synergism between 
Treponema hyodysenteriae and other selected anaerobes in gnotobiotic 
pigs. Infect. Immun. 26: 1042-1047. 
60. Wilcock, B. D. and H.J. Olander. 1979a. Studies on the pathogenesis 
of swine dysentery. I. Characterization of the lesions in the colons and 
colonic segments inoculated with pure cultures or colonic content 
containing Treponema hyodysenteriae. Vet. Pathol. 16:450-465. 
72 
61. Wilcock, B. D. and H.J. Olander. l 979b. Studies on the pathogenesis 
of swine dysentery. II. Search for a cytotoxin in spirochetal broth 
cultures and colon content. Vet. Pathol. 16:567-573. 
62. Wilson, A. 0., M. Bailey, N. A. Williams, and C. R. Stokes. 
199 J. The in vitro production of cytokines by mucosa! lymphocytes 
immunized by oral administration of keyhole limpet hemocyanin 
using cholera toxin as an adjuvant. Eur. J. lmmunol. 21: 2333-2339. 
63. Wright, J. C., G. R. Wilt, R. B. Reed, and T. A. Powe. 1989. Use 
of an enzyme-linked immunosorbant assay for detection of Treponema 
hyodysenteriae infection in swine. J. Clin. Microbiol. 27:411-416. 
64. Wu, K. C., Y. R. Mahida, J. 0. Priddle, and D. P. Jewell. 1989. 
Immunoglobulin production by isolated intestinal mononuclear cells 
from patients with ulcerative colitis and Crohn' s disease. Clin. Exp. 
Immunol. 78:37-41. 
73 
GENERAL SUMMARY 
The mucohemmorrhagic, diarrheal disease of pigs, swine dysentery, has 
had its etiologic agent, Serpulina hyodysenteriae, identified for over twenty years 
(27, 29, 106). Serotype specific antibody recognition of the LPS or endotoxin 
moiety has been demonstrated to be related to disease resistance (82). Also, in 
the mouse, immunization with cloned flagellar fragments may confer protection 
against S. hyodysenteriae induced cecitis (5, 19). Unfortunately, actual 
immunization attempts against swine dysentery have not been successful (21 , 32, 
33). Because S. hyodysenteriae does not invade beyond the lamina propria (1, 
48, 107), parenteral immunization may not induce mucosal immune protection 
against the bacteria and subsequent disease. Additionally, oral immunization 
with S. hyodysenteriae antigens may not be an efficient method of presentation to 
the gut lymphoid tissue. 
Recently , mucosal adjuvants have been used to enhance immune 
responses to different antigens (62, 67). Cholera toxin is one of these 
substances. Ovalbumin and some streptococcal antigens are poor immunogens, 
but when administered with cholera toxin they elicit an enhanced mucosal 
antibody response (1 4, 31). Protection has also been demonstrated against 
Sendai virus when cholera toxin was used as an adjuvant in vaccination. This 
protection was directly related to specific IgA titres in nasal secretions (61). 
Based on this information, the ability of cholera toxin to enhance the immune 
response of mice to S. hyodysenteriae was explored using ELISA and ELISPOT. 
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In the present studies, oral immunization with a S. hyodysenteriae 
cellular lysate primed the B lymphocyte response better than parenteral 
immunization when analysed at ten and 17 days post infection with S. 
hyodysenteriae. The B cell response was measured by assaying specific serum 
antibody titres and by assaying numbers of specific antibody secreting cells 
(ASC) in the spleen and MLN. While cholera toxin could enhance the immune 
response seen with oral immunization, serpulina antigens proved to be 
significantly immunogenic alone as demonstrated by increased numbers of 
specific ASC in the spleen and MLN over control infected mice. Further, at 30 
days post infection, infected only mice demonstrated as great a B lymphocyte 
response against S. hyodysenteriae as that observed in orally immunized mice. 
Also, western blot analysis of serum collected at ten days post infection or later 
showed antibody reactivity to flagellar and endotoxin molecules of S. 
hyodysenteriae. However, the increase in specific immunoglobuJin did not 
correlate with protection against disease. 
Specific antibody against S. hyodysenteriae may not be protective 
because it is not generated against appropriate antigens that would cause 
neutralization and/or opsonization of the bacteria. It is also possible that the 
ineffectiveness of S. hyodysenteriae specific antibody may be related to the 
damage epithelial cells receive from disease development. During swine 
dysentery, the damaged epithelium may not efficiently attach secretory 
component to dimeric IgA. The dimer is then more susceptible to enzymatic 
degradation. Swine do show serotype specific resistance to reinfection, as 
mentioned above, and lactogenic immunity (29) can be demonstrated against S. 
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hyodysenteriae. This would support the theory that a large amount of intact 
secretory IgA (S-IgA). is protective against disease. 
Cholera toxin may also not be an effective adjuvant for S. 
hyodysenteriae. Most other antigens cholera toxin has been used with were poor 
immunogens. Serpulina hyodysenteriae antigens appear to be good immunogens. 
What may be needed is not greater antibody production over natural infection, 
rather a low-level constant stimulation with antigen to ensure that there is enough 
intact S-IgA in the intestine at all times to prevent disease. 
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